Outcomes of Second Myeloablative Hematopoietic Stem Cell Transplants in Pediatric Patients with Recurrent Hematologic Malignancies (English)
- New search for: Lehmann, L. E.
- New search for: Buonanno, M.
- New search for: Duncan, C. N.
- New search for: Lehmann, L. E.
- New search for: Buonanno, M.
- New search for: Duncan, C. N.
In:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
;
14
, 2
;
74
;
2008
-
ISSN:
- Article (Journal) / Print
-
Title:Outcomes of Second Myeloablative Hematopoietic Stem Cell Transplants in Pediatric Patients with Recurrent Hematologic Malignancies
-
Contributors:
-
Published in:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION ; 14, 2 ; 74
-
Publisher:
- New search for: Elsevier Science B. V. Amsterdam
-
Publication date:2008-01-01
-
Size:74 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 617.4
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 617.4 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 14, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Targeted in vivo Expansion of Human Multipotent and Lymphoid ProgenitorsAbdel-Azim, H. / Zhu, Y. / Ge, S. / Kohn, D. B. / Crooks, G. M. et al. | 2008
- 1
-
Identification of Human Minor Histocompatibilty Antigens (mHA) by Combining Bioinformatic Prediction of Peptide Epitopes With Validation of T Cell Reactivity in Patient Blood Samples After Allogeneic Hematopoietic Stem Cell TransplantationOfran, Y. / Brusic, V. / Soiffer, R. J. / Antin, J. H. / Ritz, J. et al. | 2008
- 1
-
Mobilization of Normal Mouse Progenitors and Acute Promyelocytic Leukemia (APL) Cells With Inhibitors of CXCR4 and VLA-4 in Splenectomized and Unsplenectomized MiceRamirez, P. A. / Holt, M. / Rettig, M. / Ritchey, J. / DiPersio, J. F. et al. | 2008
- 3
-
A Multicentric Comparative Analysis of Outcomes of HLA Identical Related Cord Blood and Bone Marrow Transplantation in Patients With Beta-Thalassemia or Sickle Cell DiseaseKabbara, N. / Locatelli, F. / Rocha, V. / Ghavamzadeh, A. / Bernaudin, F. / Li, C. K. / Vermylen, C. / Stein, J. / Beruchel, A. / Cordonnier, C. et al. | 2008
- 3
-
Long-Term Follow-Up of Administration of Donor-Derived EBV-Specific CTLs to Prevent and Treat EBV Lymphoma After Hemopoietic Stem Cell TransplantHale, G. A. / Pule, M. / Amrolia, P. / Weiss, H. / Bollard, C. / Rochester, R. / Brenner, M. / Rooney, C. / Heslop, H. et al. | 2008
- 3
-
Risk Factors for Allogeneic Stem Cell Transplantation in Patients With Myelofibrosis With Myeloid MetaplasiaBaurmann, H. / Collenbusch, F. / Schmid, C. / Finke, J. / Stadler, M. / Bornhaeuser, M. / Schleuning, M. / Schwerdtfeger, R. et al. | 2008
- 5
-
Preservation of Pulmonary Diffusing Capacity with Oral Beclomethasone Dipropionate: Results From Two Randomized, Placebo-Controlled Trials in Allogeneic Graft RecipientsChien, J. W. / Gooley, T. / Sakai, M. / Schoch, H. G. / McDonald, G. B. et al. | 2008
- 5
-
Risk Factors Associated with Graft Failure After Umbilical Cord Blood Transplantation (UCBT): A Single Center Analysis in 539 PatientsDoshi, K. / Brunstein, C. G. / Cao, Q. / Wagner, J. E. et al. | 2008
- 5
-
Factors Affecting 100-Day and 1-Year Mortality Following Myeloablative Single-Unit Cord Blood Transplantation in Adults and Adolescents: A Comprehensive Meta-Analysis of CIBMTR, NCBP and EurocordCohen, Y. C. / Scaradavou, A. / Stevens, C. E. / Rubinstein, P. / Gluckman, E. / Pacheco, D. / Eapen, M. / Horowitz, M. M. / Shpall, E. J. / Laughlin, M. J. et al. | 2008
- 6
-
Costimulatory Blockade (CSB) During Mixed Lymphocyte Reaction (MLR) Prevents IL27 Upregulation and SignallingGorgun, G. / Philpot, P. A. / Naxerova, K. / Kohane, I. S. / Nadler, L. M. / Guinan, E. C. et al. | 2008
- 6
-
Risk Factor Analysis for the Development of Restrictive and Obstructive Pulmonary Function Changes After Allogeneic Stem Cell TransplantationRabanus, R. / Hahn, J. / Andreesen, R. / Holler, E. / Hildebrandt, G. C. et al. | 2008
- 6
-
Unrelated Cord Blood Transplantation (UCBT) for Transfusion-Dependent Thalassemia - a CIBMTR Audited Retrospective Analysis of 51 Consecutive PatientsJaing, T. H. / Tan, P. / Rosenthal, J. / Chan, L. L. / Lin, H. P. / Tan, P. L. / Nademanee, A. / Karanes, C. / Gjertson, D. / Wang, B. et al. | 2008
- 7
-
Unrelated Cord Blood Transplantation After Myeloablative Conditioning in 98 Adult Patients with Acute Leukemia: A Single-Institute Experience in JapanOoi, J. / Takahashi, S. / Tomonari, A. / Tsukada, N. / Konuma, T. / Kato, S. / Kasahara, S. / Tojo, A. / Asano, S. et al. | 2008
- 7
-
The Outcome of Allogeneic Stem Cell Transplantation (alloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML) Varies Considerably by Risk Factor: An Observational Study From the Center for International Blood and Marrow Transplant Research (CIBMTR)Litzow, M. R. / Perez, W. S. / Tarima, S. / Keating, A. / Sierra, J. / Tallman, M. S. / Weisdorf, D. J. et al. | 2008
- 8
-
Long-Term Results of a Gitmo Retrospective Study on Hematopoietic Stem Cell Transplantation (HSCT) for Paroxysmal Nocturnal Hemoglobinuria (PNH)Santarone, S. / Di Bartolomeo, E. / Bacigalupo, A. / Tagliaferri, E. / Iori, A. / Risitano, A. / Tamiazzo, S. / Papineschi, F. / Rambaldi, A. / Spagnoli, A. et al. | 2008
- 8
-
The Impact of Resolved Hepatitis B Infection on Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesRamos, C. A. / Saliba, R. M. / Giralt, S. / Khorshid, O. / de Padua, L. / Andersson, B. S. / Nieto, Y. L. / Popat, U. R. / Qazilbash, M. H. / Qureshi, S. et al. | 2008
- 8
-
Pre-Transplant Infusion of Naturally Occurring Donor CD4+ CD25+ T Cells Supports Donor Chimerism in MHC-Matched Allogeneic HCTShatry, A. M. / Levy, R. B. et al. | 2008
- 9
-
Utility of Co-Morbidity Assessment in Predicting Transplant-Related Toxicity Following Autologous Hematopoietic Transplantation for Multiple MyelomaLabonte, L. / Iqbal, T. / Zaidi, M. A. / McDiarmid, S. A. / Huebsch, L. B. / Tay, J. / Allan, D. S. et al. | 2008
- 9
-
Pharmacologic Inhibition of Aldehyde Dehydrogenase (ALDH) Causes The Expansion of Hematopoietic Stem Cells (HSCs) with Enhanced Engraftment CapacityMuramoto, G. G. / Himburg, H. / Meadows, S. / Salter, A. / Chao, N. J. / Chute, J. P. et al. | 2008
- 9
-
Higher CD34+ Cell Doses are Associated with Decreased Relapse Rates Following Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation with Trends to Improved Disease-Free SurvivalNakamura, R. / Auayporn, N. / Smith, D. D. / Palmer, J. / Sun, J. Y. / Schriber, J. / Pullarkat, V. / Parker, P. / Rodriguez, R. / Stein, A. et al. | 2008
- 10
-
Discovery of Leukemia Associated Minor Histocompatibility Antigens Using CD8+ T Cell Clones Isolated by Primary in vitro Stimulation of Naive T CellsBleakley, M. / Nishida, T. / Otterud, B. / Riddell, S. et al. | 2008
- 10
-
Preparation of Highly Purified Regulatory T Cells for Clinical ApplicationsSheehan, K. / Armstrong, R. / Tudisco, C. / Hou, J. Z. / Negrin, R. et al. | 2008
- 11
-
A Novel Method to Reduce Rates of Extensive Chronic GvHD (cGvHD) without Increased Relapse for Cord Blood TransplantChow, R. / Wang, B. / Rosenthal, J. / Nademanee, A. / Karanes, C. / Jaing, T. H. / Graham, M. / Delaney, C. / Gjertson, D. / Petz, L. et al. | 2008
- 11
-
Critical Role for Donor Antigen-Presenting Cell Secretion of Interleukin 23 in the Pathophysiology of Graft Versus Host Disease of the ColonDas, R. / Komorowski, R. / Ghilardi, N. / Hessner, M. / Drobyski, W. R. et al. | 2008
- 12
-
Benzodiazepine-423, an Inhibitor of Mitochondrial Respiration, Causes Selective Apoptosis of Activated Lymphocytes and Reverses Experimental GVHD While Preserving GVL EffectsGatza, E. / Clouthier, S. G. / Rogers, C. E. / Reddy, P. / Opipari, A. W. / Glick, G. D. / Ferrara, J. L. et al. | 2008
- 12
-
Epithelial Apoptosis in Oral Chronic GVHD is Mediated by Effector-Memory CD8 cells: Potential Role of IL-15Imanguli, M. M. / Swaim, W. D. / League, S. C. / Guadagnini, J. P. / Pavletic, S. Z. / Gress, R. E. / Hakim, F. T. et al. | 2008
- 12
-
IL-17 is Required for CD4-Mediated GVHDKappel, L. W. / Goldberg, G. L. / Ivanov, I. I. / Na, I. K. / King, C. / Suh, D. / Smith, O. M. / Ligh, C. / Littman, D. R. / van den Brink, M. R. et al. | 2008
- 13
-
A Fully-Human Chimeric Antigen Receptor for Redirecting Specificity of T Cells to B-Lineage TumorsManuri, P. R. / Olivares, S. / Dara, N. / Dawson, M. J. / Huls, H. / Lee, D. A. / Shpall, E. J. / Champlin, R. E. / Cooper, L. J. et al. | 2008
- 13
-
Addition of Etanercept to Methylprednisolone as Initial Therapy for Acute GVHD Results in High Response Rates and Improved SurvivalLevine, J. E. / Paczesny, S. / Mineishi, S. / Braun, T. / Choi, S. W. / Hutchinson, R. J. / Jones, D. / Khaled, Y. / Kitko, C. L. / Bickley, D. et al. | 2008
- 13
-
IL13 +2044 (Arg130Gln) Associates with Acute and Chronic Graft-Versus-Host Disease Following Haematopoietic Stem Cell TransplantationLeitch, E. A. / Harrold, J. L. / Ironside, A. / Norden, J. / Jackson, G. H. / Holler, E. / Rocha, V. / Socie, G. / Hromadnikova, I. / Sedlacek, P. et al. | 2008
- 14
-
Role of STAT3 Signaling in GVHD and GVLRadojcic, V. / Pletneva, M. A. / Yen, H. R. / Pardoll, D. M. / Drake, C. G. / Luznik, L. et al. | 2008
- 14
-
Comprehensive Typing of 1143 Single Nucleotide Polymorphisms (SNP) in 220 Immunoregulatory Genes Demonstrates That Polymorphisms in CCL3, CCL4 and CCL27 Modulate the Risk of Acute Graft Versus Host Disease (GVHD)Mullally, A. / Kim, H. / Li, C. / Mohseni, M. / Ho, V. / Alyea, E. P. / Antin, J. H. / Soiffer, R. J. / Ritz, J. et al. | 2008
- 14
-
Similar Graft-Versus-Leukemia Effect Using Matched Unrelated Donors, Compared to HLA-Identical Siblings for Hematopoietic Stem Cell TransplantationRingden, O. T. / Pavletic, S. / Anasetti, C. / Barrett, J. A. / Wang, T. / Antin, J. H. / Di Bartolomeo, P. / Bolwell, B. J. / Bredeson, C. / Cairo, M. S. et al. | 2008
- 15
-
Characterization of B Cell Target Antigens in Patients with Chronic Graft Versus Host DiseaseSarantopoulos, S. / Bhuiya, N. S. / Cutler, C. S. / Wu, C. J. / Brusic, V. / Soiffer, R. J. / Antin, J. H. / Ritz, J. et al. | 2008
- 15
-
Impact of HLA-A Disparities in HSC Transplant From Unrelated DonorsBaxter-Lowe, L. A. / Haagenson, M. D. / Wang, T. / Spellman, S. R. / Maiers, M. / Marsh, S. G. / Fernandez-Vina, M. / Hurley, C. K. et al. | 2008
- 15
-
High BAFF and BCR-activated B Cells in Patients with Progressive Chronic Graft Versus Host Disease After Rituximab TreatmentSarantopoulos, S. / Stevenson, K. E. / Kim, H. T. / Bhuiya, N. S. / Cutler, C. S. / Alyea, E. P. / Ho, V. T. / Soiffer, R. J. / Antin, J. H. / Ritz, J. et al. | 2008
- 16
-
Cytotoxic T Lymphocytes (CTL) Specific for Multiple Viruses Can Be Generated From Umbilical Cord Blood for Adoptive ImmunotherapyBollard, C. M. / Khalil, M. / Leen, A. M. / Cruz, C. R. / Decker, W. / Dotti, G. / Molldrem, J. J. / Rooney, C. M. / Heslop, H. E. / Shpall, E. J. et al. | 2008
- 16
-
Alloanergized HLA-Mismatched Bone Marrow Transplantation - Low Incidence of Clinically Significant GVHD and Viral Infection Resulting in Long Term Disease Free SurvivalDavies, J. / Gribben, J. / Brennan, L. / Nadler, L. / Guinan, E. et al. | 2008
- 17
-
Feasibility of Unrelated Umbilical Cord Blood Transplantation in Congenital Childhood DiseasesMartinez, C. / Tolar, J. / Wagner, J. E. / Tan, P. L. / DeFor, T. / Baker, K. S. / Orchard, P. J. et al. | 2008
- 17
-
Pre-Transplant Administration of Keratinocyte Growth Factor Affects Peripheral T-cell Homeostasis Through Increased Recent Thymic Emigrant Export and Affects the Course of Murine Chronic Graft-Vs.-Host DiseaseChu, Y. W. / Bodnar, D. / Singh, N. / Gress, R. et al. | 2008
- 17
-
Outcomes of a Prospective Trial of NMDP-Facilitated Unrelated Donor (UD) PBSC Hematopoietic Cell Transplantation (HCT) for Leukemia and Myelodysplasia: Comparable Survival Regardless of Regimen Intensity and Improved Survival with Higher Cell DosesPulsipher, M. A. / Chitphakdithai, P. / Logan, B. / Leitman, S. / Anderlini, P. / Klein, J. / Horowitz, M. / Miller, J. / King, R. / Confer, D. et al. | 2008
- 18
-
Administration of rhIL-7 Increases TCR Repertoire Diversity Through Preferential Expansion of Naive T CellsHakim, F. T. / Memon, S. A. / Sportes, C. / Zhang, H. / Chua, K. / Fry, T. / Engel, J. / Buffet, R. / Morre, M. / Mackall, C. et al. | 2008
- 18
-
The CD4+CD25+Foxp3+ Compartment Following Conditioning and Transplant: Host Treg Cells Expand and Comprise the Predominant Component for Several Months During Reconstitution post-HCTBayer, A. L. / Jones, M. / Urbieta, M. / Chirinos, J. / Schreiber, T. / Armas, L. / Thomas, M. R. / Levy, R. B. et al. | 2008
- 18
-
In vivo Expansion of CD4+FOXP3+ Regulatory T Cells May Contribute to Control of Acute GVHD After HLA-Mismatched Alloanergized HSCTDavies, J. / Yuk, D. / Brennan, L. / Nadler, L. / Guinan, E. et al. | 2008
- 19
-
Prospective Neurocognitive Function and Risk Factors at 5 Years After Allogeneic Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies, Compared with Controls at 5 YearsSyrjala, K. L. / Artherholt, S. B. / Kurland, B. F. / Langer, S. L. / Martin, P. J. / Roth-Roemer, S. / Abrams, J. R. / Elrod, J. B. / Dikmen, S. et al. | 2008
- 19
-
Androgen Withdrawal Modulates Thymopoiesis by Inducing Thymic Epithelial Cell Proliferation and Increasing Precursor NicheWilliams, K. M. / Lucas, P. J. / Bare, C. V. / Wang, J. / Chu, Y. W. / Gress, R. E. et al. | 2008
- 19
-
Development of Antibodies to Self Antigens K-alpha-1 Tubulin and Collagen V in Patients with Chronic Graft Versus Host DiseasePusic, I. / Saini, D. / Pavletic, S. Z. / Hakim, F. / Shannon, W. D. / Mohanakumar, T. / DiPersio, J. F. et al. | 2008
- 20
-
Increased Risk of Cervical Dysplasia in Long Term Survivors of Allogeneic Stem Cell Transplantation - Implications for Screening and HPV VaccinationSavani, B. N. / Shenoy, A. / Stratton, P. / Filie, A. / Kozanas, E. / Chauvet, D. / Donohue, T. / Le, Q. / Childs, R. W. / Goodman, S. et al. | 2008
- 20
-
Rural-Urban Disparities in Survival Outcome After Hematopoietic Stem Cell Transplantation for Hematologic MalignanciesRao, K. / Darrington, D. L. / Schumacher, J. J. / DeVetten, M. P. / Vose, J. M. / Loberiza, F. R. et al. | 2008
- 20
-
A Simplified Scoring System to Predict Day 100 Non-Relapse Mortality After Hematopoietic Stem Cell TransplantationBasu, S. K. / Liesveld, J. L. / Trawick, D. R. / Fernandez, D. / Nichols, D. / Fisher, S. G. et al. | 2008
- 21
-
A Single Dose of Gemtuzumab-Ozogamicin (GO) in Consolidation Prior to Autologous Transplant for Younger Patients with Newly Diagnosed Acute Myeloid (AML) is Safe But Has No Effect on Disease Free Survival: Interim Results of Eastern Cooperative Oncology Group Study (E1900)Fernandez, H. F. / Sun, Z. / Bennett, J. M. / Paietta, E. M. / Litzow, M. R. / Rowe, J. M. / Tallman, M. S. / Lazarus, H. M. et al. | 2008
- 21
-
National Institute of Healths Recommendation for Assessing Lung Function After Allogeneic Hematopoietic Cell Transplantation Predicts Mortality RiskWalter, E. C. / Orozco-Levi, M. / Ramirez-Sarmiento, A. / Chien, J. W. et al. | 2008
- 22
-
Rapamycin Partially Overcomes the in vitro Protective Effect of M2-10B4 Mesenchymal Stromal Cells (MSC) to Murine mCGPR/+ Acute Promyelocytic Leukemic (APL) Cells Against ChemotherapyRamirez, P. A. / Rettig, M. / Holt, M. / DiPersio, J. F. et al. | 2008
- 22
-
Inclusion of Sirolimus in the GVHD Prophylaxis Regimen is Associated with Improved Survival in Patients with Lymphoma Undergoing Allogeneic TransplantationArmand, P. / Gannamaneni, S. / Kim, H. T. / Cutler, C. S. / Ho, V. T. / Koreth, J. / Alyea, E. P. / LaCasce, A. S. / Jacobsen, E. D. / Fisher, D. C. et al. | 2008
- 23
-
Vaccination with DC/MM Fusions in Conjunction with Stem Cell TransplantationRosenblatt, J. / Vasir, B. / Wu, Z. / Bissonnette, A. / MacNamara, C. / Uhl, L. / Lenahan, C. / Miller, K. / Joyce, R. / Levine, J. D. et al. | 2008
- 23
-
Risk Factor Analysis of Outcomes After Unrelated Cord Blood Transplantation for Children with Hurlers Syndrome. An EUROCORD-Duke University Collaborative StudyBoelens, J. J. / Rocha, V. / Aldenhoven, M. / Wynn, R. / Ionescu, I. / Parikh, S. / Prasad, V. / Escolar, M. / Cavazzana-Calvo, M. / Gluckman, E. et al. | 2008
- 23
-
T-cells Redirected Against CD70 for the Immunotherapy of Hematological MalignanciesShaffer, D. / Savoldo, B. / Dotti, G. / Spencer, D. / Kenney, S. / Rooney, C. M. / Gottschalk, S. et al. | 2008
- 23
-
Predictive Value of MRD Prior to Allogeneic SCT in Relapsed Childhood Acute Lymphoblastic Leukemia - Analysis of the ALL-REZ BFM GroupBader, P. / Eckert, C. / Kreyenberg, H. / Reising, M. / Borckhardt, A. / Peters, C. / Henze, G. / Klingebiel, T. / Stackelberg, A. V. et al. | 2008
- 24
-
TNF-a and TNF Receptor Superfamily Member 1B Polymorphisms Predict Risk of Acute GVHD Following Matched Unrelated Donor BMT in ChildrenGoyal, R. K. / Fairfull, L. / Livote, E. / Yanik, G. / Ferrell, R. E. / Schultz, K. / Zorich, G. P. / Atlas, M. et al. | 2008
- 24
-
Outcomes After Hematopoietic Stem Cell Transplant (HSCT) for Non-Hodgkin Lymphoma (NHL) in Children and AdolescentsHale, G. A. / He, V. / Termuhlen, A. M. / Davies, S. M. / Camitta, B. M. / Cairo, M. S. / Eapen, M. / Gross, T. G. et al. | 2008
- 25
-
Multi-Institutional Phase II Study of Pentostatin for the Treatment of Refractory Chronic GVHD (cGVHD) in Children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) StudyJacobsohn, D. A. / Browning, B. / Gilman, A. / Lehmann, L. / Nemecek, E. / Thormann, K. / Vogelsang, G. B. et al. | 2008
- 25
-
High Resolution HLA Typing and ATG Prevent Children with all from GVHD and Treatment Related Mortality After Unrelated Donor Stem Cell TransplantationPeters, C. / Schrauder, A. / Schrappe, M. / Stackelberg, A. / Zimmermann, M. / Klingebiel, T. / Handgretinger, R. / Holter, W. / Poetschger, U. / Gadner, H. et al. | 2008
- 26
-
Lung Biopsy (Bx) has a Significantly Higher Diagnostic Yield Compared to Bronchoalveolar Lavage (BAL) in Pediatric Hematopoietic Stem Cell Transplant (HSCT) RecipientsCooney-Qualter, E. / Satwani, P. / van de Ven, C. / Baldinger, L. / Bye, M. / Bhatia, M. / Garvin, J. / George, D. / Bradley, M. B. / Schwartz, J. et al. | 2008
- 26
-
Outcomes of Unrelated Umbilical Cord Blood Transplantation in 159 Young Patients with Peroxisomal and Lysosomal Storage Disorders at a Single CenterPrasad, V. K. / Mendizabal, A. / Parikh, S. H. / Szabolcs, P. / Driscoll, T. / Page, K. / Lakshinarayanan, S. / Allison, J. / Wood, S. / Semmel, D. et al. | 2008
- 26
-
Incidence, Predisposing Factors and Outcome of Engraftment Syndrome in Pediatric Allogeneic Stem Cell Transplant RecipientsAlbert, M. H. / Stachel, D. / Schmid, I. et al. | 2008
- 27
-
Excellent Engraftment and Rapid Immune Recovery in Haploidentical Stem Cell Transplantation Using CD3/CD19 Depleted Peripheral Stem Cell Grafts After Reduced Intensity ConditioningBader, P. / Soerensen, J. / Koehl, U. / Kreyenberg, H. / Jarisch, A. / Weber, G. / Sach, G. / Willasch, A. / Kuci, S. / Tonn, T. et al. | 2008
- 27
-
Clinical Outcomes of Adolescent Patients Undergoing Hematopoietic Stem Cell TransplantMidura, B. / Lehmann, L. / Duncan, C. et al. | 2008
- 27
-
Gene Therapy for Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Comparative Results with or without PEG-ADA Withdrawal and Myelosuppressive ChemotherapyPodsakoff, G. / Engel, B. C. / Sokolic, R. / Carbonaro, D. A. / Muul, L. / Garabedian, E. / Ireland, J. / Hershfield, M. / Wayne, A. / Dunbar, C. et al. | 2008
- 28
-
Sirolimus (SRL)-Based GVHD Prophylaxis After TBI/TT/Cy Allogeneic HSCT in Pediatric Patients with HR All: Results of a Multi-Institutional Pilot StudyPulsipher, M. A. / Wall, D. / Goyal, R. / Grupp, S. / Bunin, N. et al. | 2008
- 28
-
Improved Outcome for Transplantation of Pediatric Patients with Non-Malignant Disorders with Unwashed Plasma Depleted Cord Blood (PD CB)Rosenthal, J. / Jaing, T. H. / Chan, L. L. / Eames, G. / Graham, M. / Tan, A. M. / Lin, H. P. / Nademanee, A. / Karanes, C. / Wang, B. et al. | 2008
- 29
-
Adoptive Infusion of Donor NK Cells Reduces GVHD in Recipients of T-cell Depleted and T-cell Replete Allogeneic MHC-Matched Hematopoietic Stem Cell TransplantationLundqvist, A. / Childs, R. et al. | 2008
- 29
-
Human Hematopoietic Progenitors with Slow Divisional Kinetics Reconstitute T Cells in Thymus, B Cells in Lymph Nodes and Myeloid Cells in Marrow of NOD/SCID Mouse Model and Represent the Most Primitive FractionSchubert, M. / Zoeller, M. / Ho, A. D. et al. | 2008
- 29
-
Recipient Based Strategies for Improved Transplant Efficiency: CD26 Inhibitor Treated and CD26-/- Recipient Mice Exhibit Increased Short-Term Homing and Long-Term Engraftment of Hematopoietic Stem and Progenitor CellsPaganessi, L. A. / Gregory, S. A. / Fung, H. C. / Christopherson, K. W. et al. | 2008
- 30
-
An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Diseases in HCT RecipientsHeugel, J. / Storek, J. / Young, J. A. / Kukreja, M. / Gress, R. / Tomblyn, M. / Boeckh, M. et al. | 2008
- 30
-
Prevention of Late CMV Disease After HCT: A Randomized Double-Blind Multicenter Trial of Valganciclovir (VGCV) Prophylaxis Versus PCR-guided GCV/VGCV Preemptive TherapyBoeckh, M. / Nichols, G. / Chemaly, R. / Papanicolaou, G. / Wingard, J. / Kirby, K. A. / Dahlgren, C. / Corey, L. / Leisenring, W. et al. | 2008
- 30
-
Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML FusionsRosenblatt, J. / Wu, Z. / Lenahan, C. / Bissonnette, A. / Vasir, B. / Miller, K. / Joyce, R. / Levine, J. D. / Galinsky, I. / Stone, R. et al. | 2008
- 31
-
Impact of Ribavirin Therapy on Respiratory Syncitial Virus Infection Following Hematopoietic Cell TransplantationKodali, D. / Cao, Q. / Young, J. / Orchard, P. / Burns, L. J. et al. | 2008
- 31
-
Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease Among 30-Year Survivors of Bone Marrow TransplantPergam, S. A. / Strasser, S. I. / Flowers, M. E. / Sullivan, K. M. / McDonald, G. B. et al. | 2008
- 31
-
Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkins Lymphoma: Results of a Randomized Phase II TrialRifkin, R. / Beveridge, R. / Spitzer, G. / Orloff, G. / Mandanas, R. / McGaughey, D. / Zhan, F. / Boehm, K. / Asmar, L. et al. | 2008
- 32
-
Primary CMV Infection in CMV Seronegative Recipients of a Stem Cell Product from a Seropositive Donor (D+/R-): Frequency of and Risk Factors for TransmissionSandhu, R. K. / Smith, J. / Kirby, K. A. / Heimfeld, S. / Corey, L. / Boeckh, M. et al. | 2008
- 32
-
Performance Status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), Predicts Mortality at a Canadian Transplant CentreGuilfoyle, R. / Demers, A. / Richardson, E. / Bredeson, C. / Seftel, M. et al. | 2008
- 32
-
Severe Hemorrhagic Cystitis (HC) After Allogeneic Hematopoeitic Stem Cell Transplantation (HSCT): Incidence and Risk FactorsSmith, A. R. / Tolar, J. / DeFor, T. E. / Weisdorf, D. J. / MacMillan, M. L. et al. | 2008
- 33
-
Impact of Broncho-Alveolar Lavage on the Diagnosis and Management of Pulmonary Complications Post TransplantYanik, G. / Maslak, J. / Connelly, J. / Peres, E. / Mineishi, S. / Levine, J. / Kaul, D. et al. | 2008
- 33
-
Does Respiratory Muscle Dysfunction Prior to Allogeneic Hematopoietic Cell Transplantation Influence the Risk for Mortality After Transplant?Ramirez-Sarmiento, A. / Orozco-Levi, M. / Walter, E. C. / Chien, J. W. et al. | 2008
- 34
-
Long-Term Follow-Up of Autologous Stem Cell Transplant (ASCT) in Patients with Mantle Cell Lymphoma (MCL)Al-Farsi, K. / Zadeh, S. / Nagy, T. / Franke, N. / Keating, A. / Crump, M. / Kuruvilla, J. et al. | 2008
- 34
-
Peripheral Blood Stem Cell Transplant for POEMS Syndrome is Associated with High Rates of Engraftment SyndromeDispenzieri, A. / Lacy, M. Q. / Hayman, S. R. / Kumar, S. K. / Buadi, F. / Dingli, D. / Litzow, M. R. / Gastineau, D. A. / Inwards, D. J. / Elliott, M. A. et al. | 2008
- 34
-
CD28 Controls Differentiation of Regulatory T Cells From Naive CD4 T CellsYu, X. Z. / Guo, F. / Iclozan, C. / Suh, W. K. / Anasetti, C. et al. | 2008
- 35
-
Outcome after Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Preceeding Plasma Cell DisordersKumar, S. / Dingli, D. / Dispenzieri, A. / Lacy, M. / Hayman, S. / Buadi, F. / Rajkumar, S. V. / Litzow, M. R. / Gertz, M. A. et al. | 2008
- 35
-
Autologous Stem Cell Transplant (ASCT) in First Remission for Patients with Mantle Cell Lymphoma is Associated with Prolonged SurvivalSiddiqui, M. A. / Johnston, P. B. / Inwards, D. J. / Ansell, S. M. / Porrata, L. F. / Micallef, I. N. et al. | 2008
- 35
-
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective StudyPorrata, L. F. / Inwards, D. J. / Ansell, S. M. / Micallef, I. N. / Johnston, P. B. / Gastineau, D. A. / Litzow, M. R. / Markovic, S. N. et al. | 2008
- 36
-
Autologous Hematopoietic Transplantation following High-Dose and Supralethal Chemoradiotherapy Using Stored Noncryopreserved Autologous Peripheral Blood in ColombiaCuervo-Sierra, J. / Guzman-Zapata, A. / Quevedo-Velez, A. / Duque-Martelo, J. I. / Mondragon, M. C. / Cuellar-Ambrosi, F. et al. | 2008
- 36
-
Longterm Follow-Up of Patients with Systemic AL Amyloidosis Treated with High-Dose Melphalan after Induction and Mobilization ChemotherapySchonland, S. O. / Bochtler, T. / Hansberg, M. / Mangatter, A. / Perz, J. B. / Hundemer, M. / Ho, A. D. / Goldschmidt, H. / Hegenbart, U. et al. | 2008
- 36
-
Myeloma with AL Amyloidosis: 10 Years Experience with Stem Cell TransplantSilva, L. / Weber, D. / Wang, M. / Han, E. / Mendoza, F. / de Lima, M. / Qazilbash, M. / Champlin, R. E. / Giralt, S. et al. | 2008
- 36
-
Delayed Platelet Engraftment and Outcome of Stem Cell Transplant for Multiple Myeloma: Possible Microenvironment Effect?Kumar, S. / Dispenzieri, A. / Lacy, M. Q. / Hayman, S. R. / Buadi, F. K. / Dingli, D. / Rajkumar, S. V. / Litzow, M. R. / Gertz, M. A. et al. | 2008
- 37
-
Neulasta as Growth Factor Support After Autologous Stem Cell TransplantationRice, R. D. / Baker, L. B. / Moskowitz, C. H. et al. | 2008
- 37
-
Incidence and Factors Influencing Stem Cell Mobilization in Patients with Non-Hodgkins Lymphoma (NHL) and Hodgkins Disease (HD)Popat, U. / Saliba, R. / Ahlawat, S. / Okoroji, G. J. / Alousi, A. / Anderlini, P. / Andersson, B. / de Lima, M. / Jones, R. / Kebriaei, P. et al. | 2008
- 38
-
Positron Emission Tomography Identifies a Differential Pattern of Bone Marrow FdG Uptake in "Poor" and "Good" Peripheral Stem Cell MobilizersMarcacci, G. / Caraco, C. / DArena, G. / Aloj, L. / Corazzelli, G. / Frigeri, F. / Lastoria, S. / Pinto, A. et al. | 2008
- 38
-
Radio-Immunotherapy for Low Grade Non-Hodgkins Lymphoma May Impair the Ability to Mobilize Autologous Peripheral Blood Stem CellsRaptis, A. / Mapara, M. / Bilodeau, A. / Hornyak, M. / Agha, M. E. et al. | 2008
- 38
-
Predictors of Outcome of Mantle Cell Lymphoma in Patients with Progressive Disease following Autologous Stem Cell Transplantation (ASCT)Al-Farsi, K. / Nagy, T. / Keating, A. / Crump, M. / Kuruvilla, J. et al. | 2008
- 39
-
Phase II Trial Evaluating Aprepitant (Ap) for Prevention of Nausea and Vomiting Secondary to High-Dose Cyclophosphamide (Cy) Administered to Patients Undergoing Autologous (A) Peripheral Blood Progenitor Cell (PBPC) MobilizationAbidi, M. H. / Abrams, J. / Ibrahim, R. / Ayash, L. / Cronin, S. / Al-Khadimi, Z. / Lum, L. / Ratanatharathorne, V. / Uberti, J. et al. | 2008
- 39
-
Fluid Related Complications with Filgrastim (G-CSF) 10 mcg/kg Once Daily Versus 5 mcg/kg Twice Daily in Amyloidosis Patients Undergoing Peripheral Blood Stem Cell MobilizationPerreault, S. K. / Burzynski, J. A. / Hoskin, T. L. / Leung, N. / Buadi, F. K. / Dispenzieri, A. / Hayman, S. R. / Kumar, S. K. / Lacy, M. Q. / Gertz, M. A. et al. | 2008
- 40
-
Hematopoietic Stem Cell Transplantation (SCT): A Single Center Experience in ColombiaAbello, V. / Rosales, C. / Pedraza, E. / Esguerra, H. J. / Rosales, M. L. / Linares, A. et al. | 2008
- 40
-
Pituitary Apoplexy Complicating Autologous Stem Cell TransplantationLing Cheng, K. / Devoe, C. / John, V. / Kiner, B. / Cannon, M. / Gissinger, D. / Klocke, J. / Bayer, R. L. et al. | 2008
- 40
-
Total Body Irradiation Based (TBI) Versus Chemotherapy-Based-Preparative Regimens Before Autologous Stem Cell Transplants for Non-Hodgkins LymphomaLiu, H. / Seftel, M. / Demers, A. / Schroeder, G. / Nugent, Z. / Butler, J. / Rubinger, M. et al. | 2008
- 41
-
Augmentation of Standard Umbilical Cord Blood Transplantation with ALDHbr Cells: Results of a Phase I Study in Pediatric PatientsKurtzberg, J. / Mendizabal, A. / Carter, S. / Reese, M. / Kaestner, A. / Hickerson, D. / Winstead, L. / Fiordalisi, M. / Waters-Pick, B. / Balber, A. et al. | 2008
- 41
-
Phase 1 Trial of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients With Decompensated Liver CirrhosisAlimoghaddam, K. / Mohamadnejad, M. / Mohyedin Bonab, M. / Bagheri, M. / Bashtar, M. / Ghanati, H. / Ghavamzadeh, A. / Malekzadeh, R. et al. | 2008
- 41
-
Post Thaw Colony Forming Units (CFU) is a Strong Independent Predictor of Engraftment after Unrelated Donor Umbilical Cord Blood Transplantation (UCBT)Page, K. M. / Mendizabal, A. / Waters-Pick, B. / Avrutsky, S. / Reese, M. / Prasad, V. K. / Kurtzberg, J. et al. | 2008
- 42
-
Stem Cell Recovery Following Implementation of an Automated Cord Blood Processing System in a High Volume LaboratoryRosenthal, J. / Brown, H. L. / Harris, D. T. et al. | 2008
- 42
-
Enhanced Natural Killer (NK) and NK T Cell Activation, Expansion and Cytokine Protein Production following Ex-Vivo Engineering (EvE) of Previously Cryopreserved Cord Blood (CB): Potential for CB NK and NK T Cells in Adoptive Cellular Immunotherapy (ACI)Ayello, J. / Sugarman, E. / Day, N. / Hochberg, J. / Mar, B. / Cairo, E. / van de Ven, C. / Cairo, M. S. et al. | 2008
- 42
-
IgH Gene Rearrangements in PBPC Mononuclear Cells does not Influence Survival or Relapse following Autologous Transplantation for B-cell Lymphoproliferative DiseasesHo, J. / Yang, L. / Benihashemi, B. / Martin, L. / Halpenny, M. / McDiarmid, S. / Huebsch, L. / Sabloff, M. / Atkins, H. / Bence-Bruckler, I. et al. | 2008
- 43
-
Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT)Srivastava, S. / Lundqvist, A. / Berg, M. / Yokoyama, H. / Smith, A. / McCoy, J. P. / Childs, R. et al. | 2008
- 43
-
Processing Cryopreserved Low Cell Dose Umbilical Cord Blood for Adult Transplantation with Minimal Manipulation and Cell Loss: A Single Institution ExperienceParthasarathy, M. / Rodriguez, T. / Smith, S. / Lu, S. / Stiff, P. et al. | 2008
- 44
-
The "Marrow-Miner": Efficacy of a Novel, Minimally Invasive Bone Marrow Harvesting Device in Pre-Clinical Evaluation & First Human ExperienceKraft, D. L. / Song, L. / Crocker, M. / Moseley, A. / Long, M. / Vina, R. / Ghazarossian, V. et al. | 2008
- 44
-
Cost Effectiveness of Collection Strategies for CD34+ Progenitor Cell Determinations in Autologous Hematopoietic Progenitor Cell TransplantationGriffin, D. L. / Donnenberg, A. D. / Smith, K. J. et al. | 2008
- 44
-
The Ratio of Colony Forming Unit (CFU) to Total Nucleated Cell (TNC) Count Predicts Engraftment in Umbilical Cord Blood TransplantTriplett, B. M. / Regan, D. / Wofford, J. / Schaeffler, J. / Ferguson, W. et al. | 2008
- 45
-
Characteristics and Cell Compostion of Privately Banked Autologous Umbilical Cord Blood (UCB) Units Utilized For Autologous UCB Infusion in Children with Type 1 DiabetesSmith, L. / Haller, M. J. / Staba Kelly, S. et al. | 2008
- 45
-
Determining Final Apheresis Volume for Hematopoietic Progenitor Cell (HPC) Collection Based on Intra-Procedural SamplingHackett, M. / Rahn, D. / Smilee, R. C. / Anasetti, C. / Fernandez, H. / Janssen, W. E. et al. | 2008
- 45
-
Elevated CD14+ Cell Dose in Marrow Graft Correlates with Increased Mortality after Allogeneic TransplantationArpinati, M. / Chirumbolo, G. / Nicolini, B. / De Vivo, A. / Bonifazi, F. / Giannini, M. B. / Bandini, G. / Martelli, V. / Stanzani, M. / Baccarani, M. et al. | 2008
- 46
-
Interaction of CD4+CD25+Foxp3+ Regulatory T Cells with Hematopoietic Progenitor Cells Reveals Two Distinct Pathways of RegulationUrbieta, M. / Barao, I. / Chirinos, J. / Panoskaltsis-Mortari, A. / Blazar, B. R. / Murphy, W. J. / Levy, R. B. et al. | 2008
- 46
-
Clinical Isolation and ex vivo Culturing of Cord Blood-Derived T Cells for Donor Lymphocyte InfusionUhlin, M. / Ringden, O. / Mattsson, J. et al. | 2008
- 46
-
Glycosaminoglycans as Anticoagulants in Mucopolysaccharidosis Type I (MPS I)Tolar, J. / Orchard, P. J. / Key, N. / Blazar, B. R. et al. | 2008
- 47
-
Mesenchymal Stem Cells Support ex vivo Umbilical Cord Blood Expansion by a Contact-Dependent Anti-Apoptotic EffectChu, P. / Huang, J. / Prasath, A. / Hwang, W. et al. | 2008
- 47
-
G-CSF and FLT3 Ligand Promote Recovery of Hematopoiesis after Total Body Irradiation (TBI) without Hematopoietic Stem Cell SupportGeorges, G. E. / Pillai, J. N. / Lesnikov, V. / Lesnikova, M. / Yang, Y. J. / Aragon, A. / Mielcarek, M. et al. | 2008
- 47
-
Increased Expansion, Homing and Engraftment of Cytokine-Cultured Cord Blood-Derived CD34+ Cells by Treatment with Nicotinamide, a form of Vitamin B3Peled, T. / Adi, S. / Rosenheimer, N. G. / Shoham, H. / Daniely, Y. / Nagler, A. / Rechavi, G. / Amariglio, N. / Hirsch, J. J. / Fibach, E. et al. | 2008
- 48
-
Co-Transplantation of Mesenchymal Stem Cells and Hematopoietic Stem Cells in -Thalassemia PatientsGhavamzadeh, A. / Valizadeh, N. / Alimoghaddam, K. / Karimi, A. / Bahoush, G. / Bashtar, M. / Shamshiri, A. R. / Jalili, M. / Mosavi, A. S. / Shahriari, Z. et al. | 2008
- 48
-
Mesenchymal Stem Cells Exert Differential Effects on Alloantigen- and Virus-Specific T CellsKarlsson, H. / Samarasinghe, S. / Ball, L. / Sundberg, B. / Lankester, A. C. / Dazzi, F. / Rao, K. / Veys, P. / Le Blanc, K. / Ringden, O. et al. | 2008
- 48
-
Stroma Formation from Fresh and Cryopreserved Mononuclear Cells Obtained at the Pre and Post-Mobilization Phases for Autologous Peripheral Blood Stem Cell TransplantationSchimiegue, D. M. / Silva, L. / Dreyfuss, J. L. / Zattar, K. C. / Nader, H. B. / Borelli, P. / Oliveira, J. S. et al. | 2008
- 49
-
Maintaining the in-vivo Hematopoietic Niche in-vitro; a Novel Approach to Studying Hematopoeisis in both a Murine and a Large Animal SystemKraft, D. L. / Smith, A. / Weissman, I. L. et al. | 2008
- 49
-
Establishment of Bone Marrow Stroma from Patients at Pre and Post-Mobilization for Autologous Peripheral Blood Stem Cells TransplantationSchimieguel, D. M. / Silva, L. / Dominato, J. A. / Silva, M. R. / Nader, H. B. / Borelli, P. / Souza, M. K. / Oliveira, J. S. et al. | 2008
- 49
-
Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD ProphylaxisCutler, C. / Kao, G. / Ho, V. / Alyea, E. / Koreth, J. / Armand, P. / Dey, B. / Spitzer, T. / Soiffer, R. / Antin, J. H. et al. | 2008
- 50
-
Both KIR and Its Ligand Play a Role in Hematopoietic Stem Cell Transplants (HCT)Sun, J. / Palmer, J. / Dagis, A. / Oki, A. / Gaidulis, L. / Parker, P. / Nademanee, A. / Rosenthal, J. / Falk, P. / Miller, M. et al. | 2008
- 50
-
Improved outcomes of Patients with AML/MDS Undergoing Haploidentical Stem Cell Transplantation Using Fludarabine, Melphalan and Thiotepa Conditioning ChemotherapyCiurea, S. O. / Quareshi, S. / Rondon, G. / McMannis, J. / Pesoa, S. / Cano, P. / Fernandez-Vina, M. / Giralt, S. / de Lima, M. / Champlin, R. E. et al. | 2008
- 50
-
A Retrospective Study and Matched Pair Analysis of 240 Pediatric Patients with Malignancies Transplanted with Plasma Depleted (PD) or Red Cell Reduced (RCR) Cord Blood (CB) ProductsGraham, M. / Fiederlein, R. / Wang, B. / Rosenthal, J. / Karanes, C. / Nademanee, A. / Jaing, T. H. / Chan, L. L. / Tan, P. L. / Gjertson, D. et al. | 2008
- 51
-
Clinical Characteristics of Early Onset Non-Infectious Pulmonary Complications following Cord Blood TransplantationWake, A. / Uchida, N. / Ishiwata, K. / Takagi, S. / Tsuji, M. / Kato, D. / Yamamoto, H. / Seo, S. / Matsuno, N. / Masuoka, K. et al. | 2008
- 51
-
A Two Step Approach to Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Patients with Hematologic DisordersGrosso, D. / Brunner, J. / Carabasi, M. / Dessain, S. / Filicko-OHara, J. / Mookerjee, B. / OHara, W. / Tedesco, N. / Wagner, J. L. / Flomenberg, N. et al. | 2008
- 52
-
Potential Role of a Mismatched HLA-Specific CTL Clone Developed Pre-Transplant in Graft Rejection Following Cord Blood TransplantationMurata, M. / Narimatsu, H. / Terakura, S. / Sugimoto, K. / Naoe, T. et al. | 2008
- 52
-
Characteristics of 11 Cases of Pre-Engraftment Lymphocytosis after Reduced-Intensity Cord Blood TransplantationYamamoto, H. / Wake, A. / Ishiwata, K. / Tuji, M. / Takagi, S. / Kato, D. / Matsuhashi, Y. / Sea, S. / Matsuno, N. / Uchida, N. et al. | 2008
- 52
-
Optimatch - Optimized Selection of Allele Matched Unrelated Donors from a Large DatabaseBochtler, W. / Eberhard, H. P. / Beth, M. / Mueller, C. R. et al. | 2008
- 53
-
Similar Risks for Hypothyroidism in Myeloablative and Reduced-Intensity Allogeneic Hematopoietic Cell Transplant SurvivorsAl-Hazzouri, A. / Cao, Q. / Burns, L. J. / Weisdorf, D. J. / Majhail, N. S. et al. | 2008
- 53
-
Bortezomib Plus Tacrolimus/Methotrexate for Prophylaxis of Acute GVHD after HLA Mismatched Allogeneic Non-Myeloablative Transplantation: Results of a Dose Finding Phase I StudyKoreth, J. / Kim, H. T. / Ho, V. T. / Cutler, C. S. / Soiffer, R. J. / Antin, J. H. / Alyea, E. P. et al. | 2008
- 53
-
How Realistic is it to Expect a Fully Allele Level Matched Donor from a Search Through the NMDP? A 10 Year, Single Institution ExperienceAskar, M. / Sobecks, R. / Kalaycio, M. / Dean, R. / Copelan, E. / Rybicki, L. / Pohlman, B. / Bolwell, B. et al. | 2008
- 54
-
High Prevalence of Iron Overload in Adult Survivors of Allogeneic Hematopoietic Cell TransplantationMajhail, N. S. / DeFor, T. E. / Kang, B. / Paley, C. / Lazarus, H. / Burns, L. J. et al. | 2008
- 54
-
Pre-Transplant Pulmonary Function and Day 100 Non-Relapse Mortality after Hematopoietic Stem Cell TransplantationBasu, S. K. / Liesveld, J. L. / Trawick, D. R. / Fernandez, D. / Nichols, D. / Fisher, S. G. et al. | 2008
- 54
-
Frequency of Abnormal Findings Detected by Comprehensive Evaluation at One Year after Hematopoietic Cell TransplantationLee, S. J. / Seaborn, T. / Massey, S. / Mao, F. J. / Luu, N. / Moravec, C. / Carpenter, P. A. / Martin, P. J. / Flowers, M. E. et al. | 2008
- 55
-
Impact of Health Insurance on Time to Approval and Time to Transplant Among Patients Receiving Hematopoietic Stem Cell TransplantationMcHenry, M. / Hayes-Lattin, B. / Maziarz, R. T. et al. | 2008
- 55
-
Reduced Intensity Conditioning (RIC) is Associated with Shorter Duration of Chronic GVHD than Myeloablative Conditioning and Provides Very Good Quality of Life for Long-Term Survivors after Allogeneic Stem Cell TransplantationShimoni, A. / Hardan, I. / Shem-Tov, N. / Rand, A. / Ribakovsky, E. / Yerushalmi, R. / Nagler, A. et al. | 2008
- 56
-
Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre and Post Hematopoietic Stem Cell Transplant (HSCT)Lin, M. / Epport, K. / Azen, C. / Shah, A. J. et al. | 2008
- 56
-
Measuring the Symptom Burden of Chronic Graft Versus Host DiseaseWilliams, L. A. / Neumann, J. L. / Couriel, D. R. / Mendoza, T. R. / White, M. H. / Zhang, Y. / Cleeland, C. S. et al. | 2008
- 56
-
Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemias: Impact of Imatinib on Risk of Relapse and SurvivalBurke, M. J. / Trotz, B. / Luo, X. / DeFor, T. E. / Burns, L. J. / Baker, K. S. / Weisdorf, D. J. / Wagner, J. E. / Verneris, M. R. et al. | 2008
- 57
-
Mechanism of Busulfan Resistance of Myeloid Leukemia CellsValdez, B. C. / Murray, D. / Ramdas, L. / de Lima, M. / Jones, R. / Kornblau, S. / Betancourt, D. / Li, Y. / Champlin, R. E. / Andersson, B. S. et al. | 2008
- 57
-
Long Term Remission in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Patients After Allogeneic Myeloablative Hematopoietic Cell Transplantation (HCT) Using Matched Related Donors: The 20 Year Experience at Stanford University and City of Hope National Medical CenterLaport, G. G. / Alvarnas, J. C. / Palmer, J. M. / Snyder, D. S. / Slovak, M. L. / Cherry, A. M. / Negrin, R. S. / Blume, K. G. / Forman, S. J. et al. | 2008
- 57
-
Generation of Autologous Leukemia-Reactive Cytolytic T Cells (CTL) Using a Novel Expansion Culture System: Effect of anti-CTLA-4 Versus IL-2Zhong, R. / Lane, T. A. / Ball, E. D. et al. | 2008
- 58
-
A Retrospective Audited Analysis of 107 Adult Patients with Malignancies Transplanted with Unrelated Plasma Depleted Cord Blood (PD CB)Nademanee, A. / Karanes, C. / Rosenthal, J. / Delaney, C. / Tan, P. / Jaing, T. H. / Wang, B. / Gjertson, D. / Petz, L. / Chow, R. et al. | 2008
- 58
-
Long-Term Follow-Up After Allogeneic Hematopoietic Stem Cell Transplantation For Acute Myelogenous Leukemia with a Conditioning Regimen of Total Body Irradiation and Granulocyte Colony-Stimulating Factor-Combined High-Dose CytarabineMori, T. / Aisa, Y. / Kato, J. / Ikeda, Y. / Okamoto, S. et al. | 2008
- 59
-
Treatment of Myeloid Malignancies in Elderly Patients with Fludarabine and Targeted Busulfan (t-Bu) and Allogeneic Hematopoietic Cell Transplantation (HCT)Fernandez, H. F. / Henao-Uribe, A. M. / Poling, W. H. / Chavez, J. C. / Alsina, M. / Ayala, E. / Field, T. / Kharfan-Dabaja, M. / Perez, L. / Raychaudhuri, J. et al. | 2008
- 59
-
Minimal Residual Disease Prior to Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia as a Predictor of RelapseRojas, A. M. / Song, S. X. / Corliss, A. / Truell, J. / Paquette, R. L. / Schiller, G. J. / Territo, M. C. et al. | 2008
- 59
-
Relapse of Acute Myeloid Leukmia after Allogeneic Stem-Cell Transplantation (SCT) with Myeloablative Conditioning is Associated with Longer Survival than Relapse after Reduced-Intensity Conditioning (RIC)Shimoni, A. / Hardan, I. / Shem-Tov, N. / Rand, A. / Ribakovsky, E. / Yerushalmi, R. / Nagler, A. et al. | 2008
- 59
-
Therapeutic Choices in Patients with Ph1 (+) Chronic Myelogenous Leukemia Living in Developing Countries in the Tyrosine Kinase Inhibitors (TKI) Era: Stem Cell Transplantation or TKI?Ruiz-Arguelles, G. J. / Tarin-Arzaga, L. C. / Gonzalez-Carrillo, M. L. / Gutierrez-Riveroll, K. I. / Rangel-Malo, R. / Gutierrez-Aguirre, C. H. / Cantu-Rodriguez, O. G. / Gomez-Almaguer, D. / Giralt, S. et al. | 2008
- 60
-
Second Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemias Relapsing after First Transplant in Pediatric PatientsMartinez, C. / Verneris, M. R. / Weigel, B. J. / Kumar, A. / Baker, K. S. et al. | 2008
- 60
-
Plasma and CSF Phamacokinetics (PK) and Response To Dasatinib in a Young Child with Relapsing Ph+ ALL after Allogeneic TransplantMorris, C. L. / Brown, W. C. / Zappia, J. / Morris, J. et al. | 2008
- 60
-
Feasibility of Clofarabine Cytoreduction before Initiation of Allogeneic Stem Cell Transplant Regimen During the Cytopenic Phase for Patients with Refractory Acute Myelogenous LeukemiaLocke, F. L. / Artz, A. S. / Rich, E. S. / van Besien, K. / Stock, W. et al. | 2008
- 61
-
Central Nervous System (CNS) Involvement at Diagnosis does not Adversely Affect the Outcome of High-Dose Chemotherapy and Transplant for Patients with Acute Myeloid Leukemia (AML)Petropoulos, D. / Giralt, S. A. / Andersson, B. S. / Chan, K. W. / Rondon, G. / Popat, U. R. / Hosing, C. / Alousi, A. M. / Champlin, R. E. / de Lima, M. J. et al. | 2008
- 61
-
Clofarabine Pre-Conditioning Prior to Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukaemia (AML): A Well Tolerated Regimen with Both Full and Reduced Toxicity SchedulesRichardson, D. S. / Hurlock, C. / Hill, K. / Newman, J. / McKeag, N. / Groves, L. / Orchard, K. H. et al. | 2008
- 61
-
Clinical Features of Acute Leukemia with Co-Expression of Myeloid and Lymphoid AntigensJeong, S. H. / Lee, H. W. / Kang, S. Y. / Cho, S. R. / Park, J. S. / Choi, J. H. / Kim, H. C. et al. | 2008
- 61
-
Evaluation of a Powered Intraosseous Device for Bone Marrow SamplingCohen, S. C. / Soroka, J. M. et al. | 2008
- 62
-
Unrelated Cord Blood Transplantation in Adults with Lymphoid Malignancies. A Eurocord/EBMT-Lymphoma Working Party StudyRodrigues, C. A. / Sanz, G. / Brunstein, C. / Renaud, M. / Blaise, D. / Rio, B. / Cairo, M. S. / de Lima, M. / Sureda, A. / Wagner, J. et al. | 2008
- 62
-
Reduced Intensity Versus Full Myeloablative Stem Cell Transplant for Advanced Chronic Lymphocytic LeukemiaPeres, E. / Levine, J. / Kato, K. / Krijanovski, O. / Khaled, Y. / Ferrara, J. / Yanik, G. / Mineishi, S. et al. | 2008
- 62
-
Quantitative MRD Monitoring Identifies Distinct GVL Response Patterns after Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: Results from the GCLLSG CLL3X TrialDreger, P. / Boettcher, S. / Stilgenbauer, S. / Bunjes, D. / Schubert, J. / Cohen, S. / Hallek, M. / Kneba, M. / Dohner, H. / Ritgen, M. et al. | 2008
- 63
-
Allogeneic Hematopoietic Stem Cell Transplantation has Curative Potential for Chemorefractory Non-Hodgkin LymphomaKato, K. / Krijanovski, O. / Khaled, Y. / Peres, E. / Reddy, P. / Choi, S. / Kitko, C. / Yanik, G. / Levine, J. / Ferrara, J. et al. | 2008
- 63
-
Characteristics and Outcomes of Multiple Myeloma Patients on Hemodialysis Undergoing Autologous Stem Cell Transplantation: Analysis of the US Renal Database SystemWeiss, B. M. / Neff, R. T. / Verma, P. / Agodoa, L. / Abbott, K. C. et al. | 2008
- 63
-
Long-Term Outcome of Nonmyeloalative Allografting from HLA-Identical Sibling for Multiple Myeloma (MM)Rotta, M. / Storer, B. / Sahebi, F. / Shizuru, J. A. / Benedetto, B. / Lange, T. / Agura, E. D. / McSweeney, P. A. / Pulsipher, M. A. / Hari, P. et al. | 2008
- 64
-
Autologous Stem Cell Transplantation (ASCT) for Mantle Cell LymphomaMahindra, A. / Copelan, E. / Bolwell, B. / Rybicki, L. / Dean, R. / Kalaycio, M. / Sobecks, R. / Ferraro, C. / Cherni, K. / Pohlman, B. et al. | 2008
- 64
-
Stem-Cell Collection Prior to Autologous Stem Cell Transplantation is Improved by Cyclophosphamide in Lenalidomide-Treated Patients with Multiple MyelomaMark, T. / Jayabalan, D. / Stern, J. / Furst, J. / Rambo, A. / Pearse, R. N. / Harpel, J. / Shore, T. / Schuster, M. / Leonard, J. P. et al. | 2008
- 64
-
Phase I Study of Vaccination with Dendritic Cell Myeloma FusionsAvigan, D. / Rosenblatt, J. / Vasir, B. / Wu, Z. / Bissonnette, A. / MacNamara, C. / Uhl, L. / Lenahan, C. / Miller, K. / Joyce, R. et al. | 2008
- 65
-
Long Term Follow-Up Report on Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM) and Evaluation of Prognostic Factors: Prolonged Survival for Patients with Low Heamtopoietic Cell Transplantation-Comorbitdity Index (HCT-CI) ScoreFarhat, M. / Kassar, M. / Gregory, S. A. / Venugopal, P. / Myint, R. / Go, A. / Maciejewski, J. / Fung, H. C. et al. | 2008
- 65
-
Phase I/II Trial of Bortezomib Maintenance following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple MyelomaSchiller, G. J. / Liao, M. / Sohn, J. P. / Malone, R. / Bartoni, K. / Habtemariam, B. / Paquette, R. / De Vos, S. / Territo, M. et al. | 2008
- 65
-
The "Side-Population" in Human Lymphoma Cell Lines have Increased Chemo-Resistance, Stem-Like Properties, as a Target for ImmunotherapyShafer, J. A. / Bollard, C. M. / Leen, A. M. / Rooney, C. M. / Brenner, M. K. / Foster, A. E. et al. | 2008
- 66
-
Improved Survival for Patients Undergoing Autologous Stem Cell Transplant in First or Later Remission for Primary CNS LymphomaJohnston, P. B. / ONeill, B. P. / Ansell, S. M. / Inwards, D. J. / Porrata, L. F. / Micallef, I. N. et al. | 2008
- 66
-
Allogeneic Stem Cell Transplantation for Post-Autologous Stem Cell Transplant Relapse in Hodgkin Lymphoma: Experience at a Single CenterOliva, J. L. / Kelly, J. L. / Liesveld, J. L. / Becker, M. W. / Phillips, G. L. / Sensenig, E. / Constine, L. / Bernstein, S. H. / Fisher, R. I. / Friedberg, J. W. et al. | 2008
- 66
-
A Successful Treatment Strategy for Patients with T-NHL: Allogeneic Transplantation after Beam-Alemtuzumab ConditioningGramatzki, M. / Schade, H. / Schrauder, A. / Humpe, A. / Repp, R. et al. | 2008
- 67
-
Conventional Chemotherapy with Interferon Versus Conventional Chemotherapy followed by High Dose Chemotherapy and Autologous Stem Cell Transplantation in Untreated Patients with Advanced Follicular Lymphoma. A Meta-Analysis of Randomized Clinical TrialsAyala, E. / Kumar, A. et al. | 2008
- 67
-
Identification of Graft-Versus-Myeloma Target Antigens following Syngeneic Hematopoietic Stem Cell TransplantationBiernacki, M. A. / Marina, O. / Liu, F. / Soiffer, R. J. / Ritz, J. / Anderson, K. C. / Wu, C. J. et al. | 2008
- 67
-
History of Prior Radiation Therapy Predicts Poor Progression Free Survival and Overall Survival in African Americans with Multiple Myeloma after Autologous Stem Cell TransplantationKhaled, Y. A. / Abidi, M. H. / Janakiraman, N. / Kato, K. / Hanbali, A. / Levine, J. E. / Ferrara, J. L. / Mineishi, S. et al. | 2008
- 68
-
Efficient Stem Cell Mobilization in Lenalidomide Treated Multiple Myeloma Patients Can Be Achieved by Mobilization with DCEP (Dexamethasone, Cyclophosphamide, Etoposide, Cisplatinum) followed by High-Dose G-CSFBadin, S. M. / Lendvai, N. / Gounder, S. K. / Rowley, S. / Donato, M. / Goldberg, S. / Pecora, A. / McBride, L. H. / Schmidt, L. / Donadio, K. A. et al. | 2008
- 68
-
Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)Alsina, M. / Alekshun, T. / McIsaac-Simonelli, C. / Kharfan-Dabaja, M. / Dalton, W. / Djulbegovic, B. / Fernandez, H. / Sullivan, D. M. / Ayala, E. / Field, T. et al. | 2008
- 68
-
Bortezomib Added to High-Dose Cyclophosphamide During Stem Cell Mobilization is Safe and Provides Effective Disease Control in Chemotherapy-Refractory Multiple MyelomaVoralia, M. / Fibich, C. / Katzman, M. / Danyluk, P. / George, T. / Doell, H. / Evjen, A. / vanden Berghe, J. / Briggs, S. et al. | 2008
- 69
-
Fludarabin and Cyclophosphamide Based Non-Myeloablative Conditioning Regimens in the Patients Allografted for Recurrent/Refractory Malignant Lymphoproliferative DisordersRaida, L. / Vondrakova, J. / Faber, E. / Papajik, T. / Indrak, K. / Langova, K. et al. | 2008
- 69
-
Non-Myeloablative Allogeneic Stem Cell Transplantation to Treat High Risk Heavily Pretreated MultipleMoreb, J. S. / Wirk, B. M. / Cogle, C. / Jamieson, K. J. / Hsu, J. / Wingard, J. R. et al. | 2008
- 69
-
Single Institutions Outcomes for First Transplant as Salvage Therapy for Hodgkins LymphomaShafer, J. A. / Heslop, H. E. / Carrum, G. / Kamble, R. / Myers, G. D. / Leung, K. S. / Bollard, C. M. / Krance, R. A. et al. | 2008
- 70
-
Atypical Teratoid/Rhabdoid Tumors: Improved Outcome with High-Dose ChemotherapySchechter, T. / Gassas, A. / Bartels, U. / Doyle, J. / Bouffet, E. et al. | 2008
- 70
-
The Effect of Overweight and Obesity on Intravenous (IV) Busulfan Metabolism in Children Undergoing Reduced Intensity Conditioning (RIC) for Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)Browning, B. / Thormann, K. / Coyne, K. / Kletzel, M. et al. | 2008
- 71
-
Hematopoietic Stem Cell Transplantation for Inborn Errors in Metabolism; A National Survey in JapanTakakura, H. / Shimizu, T. / Tanaka, A. / Okuyama, T. / Kato, K. / Ohashi, T. / Sakai, N. / Mugishima, H. / Suzuki, Y. / Kato, S. et al. | 2008
- 71
-
Intravenous Busulfan in Children Prior to Haematological Stem Cell Transplantation, How Narrow is the Therapeutic Window?Bartelink, I. H. / Bredius, R. G. / Egberts, T. C. / Suttorp, M. M. / Bierings, M. / Knibbe, C. / Zwaveling, J. / Boelens, J. J. et al. | 2008
- 71
-
Osteonecrosis in Pediatric Hematopoietic Stem Cell TransplantationVrooman, L. / Duncan, C. / Eaton, M. / Silverman, L. B. / Lehmann, L. et al. | 2008
- 72
-
Acute Graft-Versus-Host Disease (AGVHD) in Unrelated Cord Blood Transplantation (UCBT): Single Institution Experience, July 1996 - June 2007Alsultan, A. / Giller, R. H. / Bathurst, J. / Hild, E. / Kissane, B. / Gore, L. / Foreman, N. K. / Keating, A. / Quinones, R. R. et al. | 2008
- 72
-
Influence of Donor Age on Risk of Chronic GVHD in Sex-Mismatched Pediatric Allogenic Hematopoietic Stem Cell TransplantFriedrich-Medina, P. M. / Duncan, C. N. / Lehmann, L. E. et al. | 2008
- 73
-
Photochemically-Treated (PCT) Sensitized Cytotoxic T Cells and Anti-NK1.1 Antibody Pre-Treatment Promote Both T and B Cell Reconstitution in Non-Leaky Artemis Deficient Mice with Severe Combined Immunodeficiency Disease (SCID)Xiao, Z. / Dunn, E. / Singh, K. / Ibeid, R. / Cowan, M. J. et al. | 2008
- 73
-
Allogeneic Stem Cell Transplantation for Children with Hemoglobinopathy Using Reduced Intensity ConditioningShenoy, S. / DeBaun, M. / Kamani, N. / Adams, R. / Grimley, M. / Wall, D. / Gilman, A. / Barnes, Y. / Witty, S. / Yu, L. et al. | 2008
- 74
-
Risk Factor Analysis and EBV Load Surveillance in Pediatric Bone Marrow Transplant RecipientsJignesh, D. / Selvarangan, R. / Gonzalez, C. / Anthony, K. / Liewer, S. / Jones, R. / Shreve, N. / Kranz, K. / Chignola, B. / Ryan, R. et al. | 2008
- 74
-
Outcomes of Second Myeloablative Hematopoietic Stem Cell Transplants in Pediatric Patients with Recurrent Hematologic MalignanciesLehmann, L. E. / Buonanno, M. / Duncan, C. N. et al. | 2008
- 74
-
Extracorporeal Photopheresis (ECP) is an Effective Therapy for the Treatment of Children with Steroid Refractory (SR) Chronic Graft vs Host Disease (cGVHD)Thormann, K. / Collins, J. / Jacobsohn, D. A. / Rademaker, A. / Duerst, R. / Schneiderman, J. / Tse, W. / Kletzel, M. et al. | 2008
- 75
-
Preliminary Results of a Phase I Study of Immuno-Chemotherapy (CTX) Conditioning with Gemtuzumab Ozogamicin (GO), Busulfan (Bu) and Cyclophosphamide (Cy) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Pediatric Recipients with High Risk (HR) CD33+ Acute Myelogenous Leukemia (AML)Waxman, I. / Bhatia, M. / Qualter, E. / Jin, Z. Z. / Kohl, V. / Baldinger, L. / Guerra, J. / Garvin, J. / George, D. / Bradley, M. B. et al. | 2008
- 75
-
Co-Infusion of Matched Sibling Donor Cord Blood and Bone Marrow as Stem Cell Source for Allogeneic Stem Cell Transplantation in Pediatric Non-Malignant DisordersSoni, S. / Cowan, M. J. / Edwards, S. / Walters, M. C. et al. | 2008
- 75
-
Unrelated Donor Umbilical Cord Blood Transplant for Hemophagocytic Lymphohistiocytosis (HLH)Staba Kelly, S. / Shahlaee, A. / Szabolcs, P. / Driscoll, T. / Eslin, D. / Kurtzberg, J. / Martin, P. L. et al. | 2008
- 76
-
Low Molecular Weight Heparin (LMWH) Prophylaxis (PPX) in Pediatric Recipients following Pediatric Myeloablative Stem Cell Transplant (SCT) at High Risk for Sinusoidal Obstructive Syndrome (SOS): Is it Safe and Does it Make a Difference?Rogoza, K. / Bhatia, M. / Baldinger, L. / van de Ven, C. / Militano, O. / Qualter, E. / Cairo, M. S. et al. | 2008
- 76
-
Fluctuations in CD3+ Subset Chimerism are not Predictive of Graft Rejection in Children Undergoing Transplant for Non-Malignant DisordersOzyurek, E. / Cowan, M. / Koerper, M. / Baxter-Lowe, L. A. / Horn, B. et al. | 2008
- 77
-
Umbilical Cord Blood Stem Cell Transplants for Nonmalignant Hematopoietic DisordersWillert, J. / Rosenthal, J. / Brown, H. L. / David, H. T. et al. | 2008
- 77
-
The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT)Mohamed, A. / Niedzwiecki, D. / Baker, J. H. / Vinesett, R. / Martin, P. L. / Driscoll, T. A. / Prasad, V. K. / Parikh, S. / Kurtzberg, J. / Szabolcs, P. et al. | 2008
- 77
-
Occurrence of Graft Versus Host Disease After Hematopoietic Stem Cell Transplant Utilizing Reduced Intensity Conditioning in Pediatric PatientsDanner-Koptik, K. / Fu, J. / Dilley, K. J. et al. | 2008
- 78
-
Haploidentical Stem Cell Transplantation Using T- and B-Lymphocyte Depleted Grafts Following Reduced Intensity Conditioning for Wiskott-Aldrich SyndromeKasow, K. A. / Madden, R. / Barfield, R. / Leung, W. / Hale, G. A. et al. | 2008
- 78
-
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies After Reduced Intensity Conditioning (RIC) in Children and Young AdultsDuerst, R. E. / Jacobsohn, D. A. / Tse, W. / Schneiderman, J. / Kletzel, M. et al. | 2008
- 79
-
Successful Outcome of Allogeneic Stem Cell Transplantation for High-Risk Paediatric Acute Myeloid Leukaemia using Chemotherapy-Only Conditioning and Post Transplant ImmunotherapyBonanomi, S. / Connor, P. / Webb, D. / Ancliff, P. / Persis, A. / Rao, K. / McCloskey, D. / Hemmatpour, S. / Goulden, N. / Veys, P. et al. | 2008
- 79
-
A Novel Non-Myeloablative Conditioning Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Non-Malignant Hematological DisordersHussein, A. A. / Rihani, R. / Rahman, F. A. / Helalah, O. A. / Taani, H. A. / Nserat, T. A. / Sarhan, M. M. et al. | 2008
- 80
-
Hematopoietic Stem Cell Transplantation (HSCT) in Wiskott Aldrich Syndrome (WAS): A Single Center Experience in 25 PatientsBonfim, C. M. / Koliski, A. / Bitencourt, M. A. / Quiroga, M. / Setubal, D. C. / Funke, V. / Ruiz, J. / Medeiros, L. / Oliveira, M. / Coutinho, E. et al. | 2008
- 80
-
Iron Overload in Pediatric Hematopoietic Stem Cell Transplant (HSCT) PatientsBarry, E. V. / Chirnomas, D. / Barry, K. / Duncan, C. N. / Lehmann, L. et al. | 2008
- 80
-
Pericardial Effusion (PEF) is a Major Independent Risk Factor Associated with a Significant Decrease in Survival in Pediatric Stem Cell Transplantation (SCT) RecipientsNeier, M. / Bhatia, M. / Baldinger, L. / Silver, E. / Morris, E. / van de Ven, C. / Kleinman, C. / Jin, Z. Z. / Cairo, M. S. et al. | 2008
- 81
-
Lower Leukemia Relapse in Patients with Pulmonary Cytolytic Thrombi after Allogeneic Hematopoietic Cell TransplantVerneris, M. R. / Gulbahce, E. / Burke, M. / Cao, Q. / MacMillan, M. L. / Tolar, J. / Orchard, P. / Blazar, B. R. / Baker, S. / Wagner, J. E. et al. | 2008
- 81
-
Challenges in the Use of Hematopoietic Stem Cell Transplantation for Ectodermal Dysplasia with Immune DeficiencyFish, J. D. / Duerst, R. E. / Gelfand, E. W. / Orange, J. / Bunin, N. et al. | 2008
- 82
-
Tolerability of Dapsone in Pediatric Hematopoietic Stem Cell TransplantOConnor, M. R. / Duncan, C. / Myers, K. / Lehmann, L. et al. | 2008
- 82
-
Preliminary Results of Non-Ablative Conditioning (NAC) with Busulfan (Bu), Fludarabine (Flu) and Alemtuzumab followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease (SCD)Bhatia, M. / Baldinger, L. / Billote, G. / Morris, E. / Bradley, M. B. / George, D. / Garvin, J. / Satwani, P. / Schwartz, J. / Wolownik, K. et al. | 2008
- 82
-
Hypercalcemia after Hematopoietic Stem Cell Transplantation for OsteopetrosisMartinez, C. / Orchard, P. J. / Wagner, J. E. / Petryk, A. / Tolar, J. et al. | 2008
- 83
-
Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Schneiderman, J. / Rademaker, A. W. / Chaudry, S. / Tse, W. / Jacobsohn, D. A. / Duerst, R. / Kletzel, M. et al. | 2008
- 83
-
Outcomes of Unrelated Umbilical Cord Blood Transplantation in Pediatric Patients with Myelodysplastic SyndromeParikh, S. H. / Mendizabal, A. / Martin, P. L. / Szabolcs, P. / Prasad, V. K. / Driscoll, T. A. / Kurtzberg, J. et al. | 2008
- 83
-
Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning RegimenKennedy-Nasser, A. A. / Myers, G. D. / Leung, K. S. / Gottschalk, S. / Bollard, C. M. / Heslop, H. E. / Brenner, M. K. / Krance, R. A. et al. | 2008
- 84
-
Single Daily Dose (SDD) Busulfan (Bu) in Children: Comparison of Pharmacokinetics (PK) and Engraftment between Acute Leukaemia (AL) and Non Malignant Disease (NM)Shaw, P. J. / Nath, C. E. / Earl, J. W. et al. | 2008
- 84
-
The Addition of Etoposide to Bu16/Cy200 in the Conditioning of Children with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Stem Cell Transplantation (SCT) is Associated with Improved SurvivalAyas, M. / Al-Mahr, M. / Al-Jefri, A. / Al-Seraihi, A. / Belgaumi, A. / Al-Ahmari, A. / El-Hassan, I. / El-Solh, H. et al. | 2008
- 84
-
Fungal Infections: A Survey of Pediatric Survey of Pediatric Blood & Marrow Transplant Consortium InstitutionsFisher, V. L. / Olson, E. A. et al. | 2008
- 85
-
Resolution of IPEX and Achievement of Complete Donor CD3+CD4+ T-cell Engraftment following a Reduced Intensity Conditioning Regimen and Infusion of a T- and B-Lymphocyte Depleted Allogeneic Bone Marrow GraftWichlan, D. G. / Shurtleff, S. A. / Riberdy, J. M. / Kasow, K. A. et al. | 2008
- 85
-
Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in AdultsWaxman, I. / Bhatia, M. / Milone, M. / Shaw, L. M. / Baldinger, L. / Militano, O. / Garvin, J. / George, D. / Bradley, M. B. / Satwani, P. et al. | 2008
- 86
-
Viral Infections: A Survey of Pediatric Blood and Marrow Transplant Consortium InstitutionsOlson, E. A. / Fisher, V. et al. | 2008
- 86
-
Intensive Care Unit Admission of Pediatric HSCT Patients following Initial Transplant DischargeDuncan, C. / Buonanno, M. / Clark, J. / Lehmann, L. et al. | 2008
- 86
-
Sirolimus, Tacrolimus and Fluconazole Pharmacokinetics in Pediatric BMT RecipientsGoyal, R. K. / Venkataramanan, R. / Mada, S. R. / Krasowski, M. / Grupp, S. / Wall, D. / Bunin, N. / Pulsipher, M. et al. | 2008
- 87
-
Long Term Follow-Up in Three Pediatric Patients with Farber Disease, Type 2/3, following Allogeneic Hematopoietic Stem Cell Transplantation from Related and Unrelated DonorsEhlert, K. / Frosch, M. / Roth, J. / Juergens, H. / Vormoor, J. et al. | 2008
- 87
-
Cerebral Toxoplasmosis following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Malignant Lymphoma: Misinterpretation as Relapsed Lymphoma on Initial MRI StudiesFroehlich, B. / Florax, A. / Juergens, H. / Groll, A. H. / Ehlert, K. et al. | 2008
- 87
-
Busulfan and Single-Dose Melphalan as Preparative Therapy for Infants and Young Children Undergoing Stem Cell Transplantation for Leukemia: A Single Center ExperienceGraham, M. L. / Andreansky, M. / Katsanis, E. / Wood, T. S. / Hutter, J. J. et al. | 2008
- 87
-
Evaluating Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Pediatric Patients Receiving Bone Marrow TransplantationKim, A. / Tse, J. / Moore, T. B. et al. | 2008
- 88
-
Unrelated Donor Cord Blood Stem Cell Transplantation for Leukocyte Adhesion Deficiency (LAD)Robertson, K. A. / Goebel, W. S. / Renbarger, J. L. / Jude, V. / Gowan, D. / Towell, P. / Lorch, C. / Collura, J. / Haut, P. R. et al. | 2008
- 88
-
Duration of Hospitalization in the First 100 Days following Reduced Intensity Conditioning for Non-Malignant Disorder Transplants in ChildrenWitty, S. / Barnes, Y. / Yu, L. / Gilman, A. / Nieder, M. / Adams, R. / Dalal, J. / Pulsipher, M. / Kamani, N. / Grimley, M. et al. | 2008
- 89
-
Outcome of Allogeneic Stem Cell Transplantation for 26 Children with Myeloid Leukemia in Single CenterChen, J. / Jiang, H. / Dong, L. / Luo, C. / Wang, Y. et al. | 2008
- 89
-
High Dose Chemotherapy followed by Stem Cell Rescue in Adolescents with Ewings SarcomaTatman, D. J. / Rumelhart, S. L. / Radhi, M. A. et al. | 2008
- 89
-
Successful Combined Unrelated Umbilical Cord Blood Haploidentical Transplant in Non Malignant DiseaseKleiner, G. I. / Barredo, J. / Shariatmadar, S. / Khan, A. / Pahwa, R. / Rodriguez, M. / Willumsen, S. / Podda, A. / Fernandes, C. / Alvarez, O. et al. | 2008
- 89
-
Unrelated Cord Blood Transplantation (UCBT) in Pediatric Patients: A Single Center Experience in ChileBarriga, F. J. / Wietstruck, M. A. / Zuniga, P. et al. | 2008
- 90
-
Treatment of Epstein Barr Virus Positive Nasopharyngeal Carcinoma with Adoptively Transferred Cytotoxic T LymphocytesLouis, C. U. / Straathof, K. / Gerken, C. / Cooper-Havlik, D. / Torrano, V. / Lopez, T. / Bollard, C. M. / Gresik, M. V. / Weiss, H. / Gee, A. et al. | 2008
- 90
-
Regression of Experimental Osteosarcoma and Ewings Sarcoma following Transfer of HER2-Redirected T CellsAhmed, N. / Salsman, V. S. / Louis, C. L. / Dishop, M. / Weiss, H. L. / Kleinerman, E. S. / Rooney, C. M. / Heslop, H. E. / Gottschalk, S. et al. | 2008
- 90
-
Autologous Stem Cell Transplantation in Children with Refractory or Relapsed Hodgkin Disease in ColombiaLinares, A. / Abello, V. / Rosales, C. / Pedraza, E. / Esguerra, H. J. / Rosales, M. L. et al. | 2008
- 91
-
Optimizing Immunotherapy Immediately after Hematopoietic Stem Cell Transplantation (HSCT) to Effectively Treat Established NeuroblastomaJing, W. / Yan, X. / Orentas, R. J. / Johnson, B. D. et al. | 2008
- 91
-
High-Dose Chemotherapy with Autologous Stem-Cell Support Versus Standard-Dose Chemotherapy for High-Risk Breast Cancer: Meta-Analysis of Individual Patient Data from 15 Randomized Adjuvant TrialsUeno, N. T. / Berry, D. A. / Johnson, M. M. / Lei, X. / Lopez, V. T. / Caputo, J. A. / Bregni, M. / Demirer, T. et al. | 2008
- 91
-
KIR Receptor-Ligand Incompatibility Predicts Susceptibility of Osteosarcoma to NK-Mediated LysisDelgado, D. / Hardin, H. / Webster, D. / DeSantes, K. / Shaaban, A. et al. | 2008
- 92
-
Prolonged Survival for Ultra High-Risk Pediatric Sarcoma Patients following Reduced-Intensity Allogeneic Stem Cell Transplantation (AlloSCT)Baird, K. / Love, C. / Steinberg, S. M. / Mackall, C. L. / Wayne, A. S. / Fry, T. J. et al. | 2008
- 92
-
Long-Term Clinical Outcome of High Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation (HDCT/ASCT) for Breast Cancer PatientsJeong, S. H. / Lee, H. W. / Kang, S. Y. / Park, J. S. / Choi, J. H. / Kim, H. C. et al. | 2008
- 93
-
Diminished Biological Potency of BM-Derived CD133+ Cells Obtained from Patients with Coronary Artery Disease in in vitro and in vivo StudiesGreco, N. J. / Finney, M. / Joseph, M. / Hammond, L. R. / Forester, M. / Bhakta, S. / Goldberg, J. / Scheid, P. / Victor, A. / Pompili, V. J. et al. | 2008
- 93
-
Mobilization of Murine HSCs with AMD15057, A Small Molecule Inhibitor of CD49d (VLA4)Ramirez, P. A. / Rettig, M. / Holt, M. / Ritchey, J. / DiPersio, J. F. et al. | 2008
- 93
-
Impact of Storage Conditions on Marrow and Peripheral Blood Stem Cell Products Stored Over 72 HoursKao, G. / Kim, H. / Gatzo, L. / Madison, H. / Daley, H. / Perzepiorka, D. / Burger, S. / Kelley, L. / Vierra-Green, C. / Flesch, S. et al. | 2008
- 94
-
Potential Biodosimetry Markers of Radiation ExposureUpton, A. / Kharbanda, S. / Sande, J. E. / Gage, J. / Wang, D. / Johnson, M. et al. | 2008
- 94
-
Rescue Mobilization of Hematopoietic Progenitor Cells with AMD3100 + G-CSF is Successful in Patients Who Previously Failed MobilizationMicallef, I. N. / Ansell, S. M. / Buadi, F. / Dispenzieri, A. / Elliott, M. A. / Gertz, M. A. / Hayman, S. R. / Hogan, W. J. / Inwards, D. J. / Gastineau, D. A. et al. | 2008
- 94
-
AMD3100 Mobilizes a More Primitive Hematopoietic Progenitor Subset from Human MarrowWagner, W. / Fruhauf, S. / Callandra, G. / Ho, A. D. et al. | 2008
- 95
-
Voriconazole is Effective Prophylaxis for Aspergillus Invasive Fungal Infection (IFI) in Patients Receiving Glucocorticosteroid Therapy for GVHD after Allogeneic TransplantationGergis, U. / Markey, K. / Greene, J. / Kharfan-Dabaja, M. / Wetzstein, G. / Anasetti, C. / Perkins, J. et al. | 2008
- 95
-
Decrease of HHV6 DNAemia following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chromosomally Integrated HHV6Hubacek, P. / Hrdlickova, A. / Muzikova, K. / Hyncicova, K. / Pohlreich, D. / Cetkovsky, P. / Sedlacek, P. et al. | 2008
- 95
-
Treatment of Donor Graft Failure with Autologous or Allogeneic Stem Cell Boost or a Second Allogeneic Transplant Based on Chimerism TestingShimoni, A. / Shem-Tov, N. / Rand, A. / Ribakovsky, E. / Yerushalmi, R. / Hardan, I. / Nagler, A. et al. | 2008
- 96
-
Comparison of Incidence of Systemic Viral Infection (SVI) and Invasive Fungal Infection (IFI) in Children Receiving Busulfan Based Reduced Intensity Allogeneic Stem Cell Transplant (RIAlloSCT) vs. Myeloablative AlloSCT (MA-AlloSCT) for Malignant and Non-Malignant DiseasesSatwani, P. / Freedman, J. / Baldinger, L. / Guerra, J. / van de Ven, C. / Jin, Z. Z. / Garvin, J. / George, D. / Bradley, M. B. / Bhatia, M. et al. | 2008
- 96
-
The Prevalence and Determinants of the Use of Complementary and Alternative Medicine in Hematopoietic Stem Cell Transplantation PatientsAksoy, S. / Kocal, N. / Akdogan, S. / Ozdemir, E. et al. | 2008
- 97
-
Current Epidemiology of Oral Candida Colonization in Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation: A Longitudinal, Prospective StudyToro, J. J. / Westbrook, S. D. / Kirkpatrick, W. R. / Fothergill, A. W. / Patterson, T. F. / Redding, S. W. / Freytes, C. O. et al. | 2008
- 97
-
Prospective Monitoring of Nutritional Status During the Early Phase after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Fuji, S. / Kamiya, S. / Kim, S. W. / Sugiyama, M. / Fukuda, T. / Mori, S. I. / Kurosawa, S. / Yokoyama, H. / Saito, B. / Takahashi, T. et al. | 2008
- 97
-
The Popsickle with Strawberry Aroma Reduces Infusion-Related Nausea and Vomiting During the Infusion of Cryopreserved Peripheral Blood Stem CellsAkgedik, K. / Akdogan, S. / Aksoy, S. / Ozdemir, E. et al. | 2008
- 98
-
Daptomycin Plus Cefepime for Moderate and High-Risk Febrile Neutropenic Patients with Increased Risk of Gram-Positive InfectionRossetti, J. M. / Thatikonda, C. / Shadduck, R. K. / Sahovic, E. / Kaplan, R. B. / Kennedy, M. / Lister, J. et al. | 2008
- 98
-
Usefulness of Bronchoscopic Lavage in Intensive Care Unit for Critically Ill Stem Cell Transplant Recipients with Pulmonary InfiltratesGhosh, S. / Finch, C. G. / Champlin, R. E. / Kebriaei, P. / Giralt, S. A. / Pravinkumar, S. E. et al. | 2008
- 98
-
Larger Stem Cell Dose is Associated with Decreased Symptom Severity after Autologous Stem Cell Transplantation for Multiple MyelomaWilliams, L. A. / Giralt, S. A. / Mendoza, T. R. / Anderson, K. O. / Mobley, G. M. / Saliba, R. M. / Qazilbash, M. H. / Campagnaro, E. L. / Cleeland, C. S. et al. | 2008
- 99
-
Update on Fungal Infections in Pediatric Bone Marrow Transplant Patients at the Mattel Childrens Hospital at UCLA from 1991-2006Simms-Waldrip, T. R. / Rosen, G. P. / Kempert, P. H. / Nielsen, K. / Moore, T. B. et al. | 2008
- 99
-
A Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Hematology-Oncology Patients with Febrile Neutropenia (FN)Bubalo, J. S. / Ciszewski, A. O. / Kovascovics, T. J. / Meyers, G. / Mauro, M. / Epner, E. / Jones, N. / Hayes-Lattin, B. / Deninger, M. / Curtin, P. T. et al. | 2008
- 100
-
Recombinant Factor 7a in Paediatric Stem Cell Transplant Supportive CareJessop, M. E. / Lockwood, L. R. / Hallahan, A. / Smith, E. K. / Little, M. A. et al. | 2008
- 100
-
Air Filtration in Stem Cell Transplant Units: Is It Always Necessary?Wood, C. E. / Johnson, L. R. / Carter, J. M. / Anthony, B. et al. | 2008
- 100
-
BK and JC Polyomavirus Viremia in Allogeneic Hematopoietic Cell Transplant Patients: Therapeutic Role of FoscarnetOholendt, M. S. / Kamble, R. T. / Carrum, G. et al. | 2008
- 100
-
Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes from a CMV Sero-Negative Donor for Persistent CMV Infection Post-TransplantLucas, K. / Cowan, M. / Horn, B. / Dunham, K. / Bao, L. et al. | 2008
- 101
-
Levofloxacine Antibacterial Prophylaxis for Patients Treated with High Dose Chemotherapy and Autologous Stem Cell TransplantationCasas, C. P. / Abello, V. / Rosales, C. / Pedraza, E. / Esguerra, H. / Linares, A. / Rosales, M. L. et al. | 2008
- 102
-
A Prospective Evaluation of the Effect of Polyoma (BK) Virus Infection on the Incidence of Hemorrhagic Cystitis (HC) after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (UD HSCT)Silva, L. / Patah, P. / Szewczyk, N. / Saliba, R. M. / Gilman, L. / Gulbis, A. / Neumann, J. / Walker, J. A. / Petropoulos, D. / El-Zimaity, M. et al. | 2008
- 102
-
Myeloablative Transplantation from Matched Siblings (MSD) using a Daily Intravenous Busulfan (Bu)/fludarabine (Flu) Regimen with Thymoglobulin (TG): Analysis Involving 200 Patients Indicates Low Transplant-related Mortality (TRM) in all but Older Patients with High-risk DiseaseRussell, J. / Duan, Q. / Chaudhry, A. / Brown, C. / Bahlis, N. / Savoie, L. / Daly, A. / Geddes, M. / Storek, J. / Balogh, A. et al. | 2008
- 102
-
Graft Rejection Following Dog Leukocyte Antigen (DLA)-Identical Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Results in Long-Term Increases in Host T Regulatory (Treg) CellsGeorges, G. E. / Lesnikova, M. / Hwang, B. / Abrams, K. / Nash, R. A. et al. | 2008
- 103
-
Serological Evidence of Hepatitis C is Associated with Worse Non-Relapse Mortality and Overall Survival after Allogeneic Stem Cell TransplantationRamos, C. A. / Saliba, R. M. / Khorshid, O. / de Padua, L. / Giralt, S. / Andersson, B. S. / Ueno, N. T. / Shpall, E. J. / Hosing, C. / Qureshi, S. R. et al. | 2008
- 103
-
Modification of T cell Responses by Stem Cell Mobilization Requires Direct Signalling of the T cell by G-CSF and IL-10MacDonald, K. P. / Bofinger, H. M. / Kuns, R. D. / Morris, E. S. / Don, A. L. / Banovic, T. / Hill, G. R. et al. | 2008
- 103
-
Treosulfan Plus Fludarabine for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Leukemia and Myelodysplastic SyndromeNemecek, E. R. / Ly, B. / Kovacsovics, T. / Maziarz, R. T. / Baumgart, J. / Sanders, J. E. / Deeg, H. J. et al. | 2008
- 104
-
Serial Voriconazole Therapeutic Drug Monitoring in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationTrifilio, S. M. / Yarnold, P. R. / Pennick, G. / Pi, J. C. / Golf, M. / Fishman, M. / Masino, K. / Mehta, J. et al. | 2008
- 104
-
Efficient Induction and Isolation of a Primary CMV-specific CD8+ T Cell Response from CMV Seronegative Donors for the Treatment of Serious CMV-Related Complications in CMV Seropositive Patients Transplanted with a CMV Seronegative DonorJedema, I. / van de Meent, M. / van der Heiden, P. L. / Marijt, E. W. / Meij, P. / Willemze, R. / Falkenburg, J. H. et al. | 2008
- 105
-
The use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate to Prevent Graft-Versus-Host Disease following Unrelated Donor Hematopoietic Stem Cell TransplantationNakamura, R. / Rodriguez, R. / Palmer, J. / Nademanee, A. / Sun, J. / Senitzer, D. / Pullarkat, V. / Aljitawi, O. / Zain, J. / Snyder, D. et al. | 2008
- 105
-
Graft Rejection as a Type I Immune Response Amenable to Modulation by Type II Donor T Cells via an "Infectious" MechanismMariotti, J. / Foley, J. / Amarnath, S. / Buxhoeveden, N. / Ryan, K. / Costanzo, C. M. / Fowler, D. H. et al. | 2008
- 105
-
Applying the Hematopoietic Cell Transplantation-comorbidity Index (HCT-CI) in Myeloablative MUD Transplants Predicts NRM and OS using a Modified 2-group Scoring SystemKovacsovics, T. / Park, B. / Hayes-Lattin, B. / Dunn, A. / Curtin, P. T. / Leis, J. F. / Epner, E. E. / Meyers, G. / Maziarz, R. T. et al. | 2008
- 106
-
Lipopolysaccharide Binding Protein Promoter Variants Influence the Risk for Gram-negative Bacteremia and Mortality after Allogeneic Hematopoietic Cell TransplantationChien, J. W. / Boeckh, M. / Hansen, J. A. / Clark, J. G. et al. | 2008
- 106
-
Healthy Allogeneic Related Donors of Peripheral Haematopoietic Progenitors: A Long-term Prospective StudyTassi, C. / Arpinati, M. / Giudice, V. / Bontadini, A. et al. | 2008
- 106
-
Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 PatientsYokoyama, H. / Fukuda, T. / Kobayashi, Y. / Kim, S. W. / Maruyama, D. / Mori, S. I. / Watanabe, T. / Tanosaki, R. / Tajima, K. / Tobinai, K. et al. | 2008
- 107
-
Comparison of Outcomes in Children Undergoing a Single Allogeneic Transplant using Bone Marrow (BM) or Umbilical Cord Blood (UCB) as Stem Cell Source. The Childrens Memorial Hospital ExperienceMerchant, M. / Huang, W. / Kletzel, M. et al. | 2008
- 107
-
Pre-transplant Seum C-peptide Level Predicts for Post-transplant Diabetes Mellitus (PTDM) after Allogeneic Stem Cell Transplant (SCT)Jagasia, S. / Perkins, J. / Survant, M. / Chen, H. / Jagasia, M. et al. | 2008
- 107
-
Impact of Longitudinal Long Term Transplant Clinic (LTTC) on Survival after Allogeneic Stem Cell Transplant (SCT)Jagasia, M. / Clifton, C. / Vaughan, L. A. / Chinratanalab, W. / Chen, H. / Dixon, S. / Hunt, C. / Kassim, A. et al. | 2008
- 108
-
Triple Postgrafting Immunosuppression Fails to Prevent Graft Rejection in Dogs given DLA-Identical Marrows after 1 Gy Total Body Irradiation (TBI)Sorror, M. / Leisenring, W. / Mielcarek, M. / Baron, F. / Diaconescu, R. / Hogan, W. / Graves, S. / Storb, R. et al. | 2008
- 109
-
Predictors and Impact of Donor T-cell Chimerism in Myeloablative Allogeneic Stem Cell TransplantationDean, R. M. / Sobecks, R. / Rybicki, L. / Brown, S. / Copelan, E. / Kalaycio, M. / Pohlman, B. / Sweetenham, J. / Andresen, S. / Bolwell, B. J. et al. | 2008
- 109
-
Allogeneic Hematopoietic Cell Transplantation (HCT) in Chemotherapy Refractory Chronic Lymphocytic Leukemia (CLL)Aljitawi, O. S. / Krishnan, A. / Nademanee, A. / Palmer, J. / Alvarnas, J. / Cai, J. L. / Kirschbaum, M. / Kogut, N. / Nakamura, R. / Popplewell, L. et al. | 2008
- 110
-
Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and do not Increase the Incidence of Graft Versus Host Disease (GVHD) following Unrelated Donor Blood Stem Cell Transplantation (SCT)Narayanan, S. / Barnett, M. J. / Abou Mourad, Y. R. / Forrest, D. L. / Hogge, D. E. / Lavoie, J. C. / Nantel, S. H. / Shepherd, J. D. / Song, K. W. / Sutherland, H. J. et al. | 2008
- 110
-
Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-donors (MDT) in Humans Offers better Engraftment as Compared to Single Haploidentical DonorShapira, M. Y. / Resnick, I. B. / Gesundeheidt, B. / Samuel, S. / Drey, L. / Verkholevsky, Y. / Slavin, S. / Or, R. et al. | 2008
- 110
-
Patients Socioeconomic Status as a Prognostic Factor for Allogeneic Stem Cell TransplantationSilla, L. / Fischer, G. / Mitto, I. / Grossini, M. / Bittencourt, H. / Astigarraga, C. / Daudt, L. / Bittencourt, R. / Paz, A. et al. | 2008
- 110
-
Salvage Transplantation for Allograft Failure Utilizing Fludarabine and Alemtuzumab as the Conditioning RegimenBolanos-Meade, J. / Luznik, L. / Jones, R. J. / Fuchs, E. J. et al. | 2008
- 111
-
Once Daily Busulfan Cyclophosphamide is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell TransplantationLeMaistre, J. / Bachier, C. / Smith, B. / LeMaistre, C. F. / Shaughnessy, P. J. et al. | 2008
- 111
-
The Relation Between the Frequency of Presence of Thrombophilia and Thromboembolic Complications After Allogeneic Hematopoietic Cell Transplantation (AHCT)Topcuoglu, P. / Gunaltay, S. / Dalva, K. / Bilgin, A. U. / Arat, M. / Ozcan, M. et al. | 2008
- 111
-
The Impact of the Disparities of Short Tandem Repeats (STR) between Doonor-recipient Pair on the Allogeneic Hematopoietic Cell Transplantation (AHCT) OutcomeSerbest, E. / Topcuoglu, P. / Dalva, K. / Bilgin, A. U. / Soydan, E. A. / Ozcan, M. / Arslan, O. / Ilhan, O. / Beksac, M. / Gurman, G. et al. | 2008
- 112
-
Effect of Substituting Fludarabine and Thymoglobulin for Cyclophosphamide in Busulfan-based Conditioning Regimens on T-cell Chimerism and outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)ODonnell, P. V. / Woolfrey, A. E. / Storer, B. / Sorror, M. L. / Furlong, T. / Anasetti, C. / Heimfeld, S. / Flowers, M. / Appelbaum, F. R. / Martin, P. J. et al. | 2008
- 112
-
Role of Extensive Splenomegaly in Patients with Myelofibrosis undergoing a Reduced Intensity Allogeneic Stem Cell TransplantCiurea, S. O. / Sadegi, B. / Wilbur, A. / Alagiozian-Angelova, V. / Gaitonde, S. / Dobogai, L. / Akard, L. P. / Hoffman, R. / Rondelli, D. et al. | 2008
- 112
-
An Evaluation of DNA Methylation Changes in a Phase I Clinical Trial of Low-dose 5-azacitidine (AZA) given as Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Silva, L. / Garcia-Manero, G. / Giralt, S. / McCormick, G. / Soriano, A. / Champlin, R. / Kantarjian, H. / de Lima, M. et al. | 2008
- 113
-
Thymoglobulin Rabbit Anti-thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and does not Suppress Granulocyte Engraftment in a Non-myeloablative Stem Cell Transplantation SettingShapira, M. Y. / Resnick, I. B. / Gesundeheidt, B. / Bitan, M. / Ackerstein, A. / Samuel, S. / Drey, L. / Verkholevsky, Y. / Slavin, S. / Or, R. et al. | 2008
- 113
-
A Comparison of Measured vs. Calculated Creatinine Clearance and their Lack of Association with Renal Regimen Related Toxicity after Autologous and Allogeneic BMTHahn, T. / Dunford, L. / Butler, B. / Stento, N. / Smiley, S. / Battiwalla, M. / McCarthy, P. L. et al. | 2008
- 113
-
Myeloablative Allogeneic Stem Cell Transplantation in 424 Patients using Busulfan and CyclophosphamideFloisand, Y. / Tjonnfjord, G. E. / Gedde-Dahl d.y., T. / Heldal, D. / Egeland, T. / Dybedal, I. / Holme, P. A. / Brinch, L. C. et al. | 2008
- 114
-
Pretransplantation Assessment of Mortality (PAM) Risk Score can Predict Cost for Patients Submitted to Autologous and Allogeneic Hematopoietic Stem Cell TransplantationKerbauy, F. R. / Ribeiro, A. F. / Toledo, C. / Lisboa, L. F. / Hamerschlak, N. et al. | 2008
- 114
-
Rapid Engraftment and Low Rates of Graft-versus-host Disease (GVHD) Following Reduced Intensity Conditioning (RIC) with Fludarabine/Busulfan/ATG (FBA) and Stem Cell Transplantation (SCT) using Unrelated Donors (URD)Hamadani, M. / Awan, F. T. / Elder, P. / Lin, T. S. / Andritsos, L. / Blum, W. / Blum, K. A. / Devine, S. M. et al. | 2008
- 114
-
Factors and Predictors Associated with Peripheral Blood Stem Cell Yield in Volunteer Donors-Taiwan ExperienceChen, S. H. / Lu, C. J. / Wen, S. H. / Shyr, M. H. / Yang, K. L. et al. | 2008
- 115
-
Dog Leukocyte Antigen (DLA)-identical Sibling Cord Blood Transplantation (CBT) Following Myeloablative Total Body Irradiation (TBI)Lesnikov, V. / Baran, S. / Abrams, K. / Zellmer, S. / Yang, Y. J. / Heimfeld, S. / Lesnikova, M. / Nash, R. A. / Georges, G. E. et al. | 2008
- 115
-
Tacrolimus Dosing in Allogeneic Hematopoietic Stem-Cell Transplantation Recipients Receiving VoriconazoleTrifilio, S. M. / Pi, J. / Singhal, S. / Frankfurt, O. / Evens, A. / Gordon, L. / Tallman, M. / Winter, J. / Williams, S. / Mehta, J. et al. | 2008
- 115
-
Allogenic Stem Cell Transplantation in Patients with Acquired Aplastic Anemia and Fanconni Anemia: A Single Center Experience over 11 YearsRosales, C. / Abello, V. / Esguerra, H. J. / Pedraza, E. / Linares, A. / Rosales, M. L. et al. | 2008
- 116
-
Development and Anti-BALB.B Reactivity of T Cells Emerging from Bone Marrow Cells Transduced with a Clonal TCRVb14-Jb2.4 SequenceAppel, M. Y. / Friedman, T. M. / Korngold, R. et al. | 2008
- 116
-
Low Relapse Rate after Allogeneic-SCT Following a Myeloablative Preparative Regimen with Flamsa Chemotherapy and Toxicity-Reduced Conditioning in Patients with High Risk Myeloid Malignancies Aged 60 Years or OlderSchleuning, M. / Judith, D. / Heshmat, M. / Burlakova, I. / Taube, R. / Jedlickova, Z. / Baurmann, H. / Kolb, H. J. / Schwerdtfeger, R. et al. | 2008
- 116
-
Similar Survival after Sibling vs Unrelated Donor Allogeneic Stem Cell Transplantation with Reduced Intensity ConditioningStein, S. / Goldstein, S. C. / Smith, J. / Luger, S. / Loren, A. / Stadtmauer, E. / Schuster, S. / Nasta, S. / Tsai, D. / Perl, A. et al. | 2008
- 117
-
Impact of Prophylactic Red Blood Cell Exchange for Prevention of Severe Immune Hemolysis in Pediatric Minor ABO-Mismatched Allogeneic Peripheral Blood Progenitor Cell TransplantationBolotin, E. / Rosenthal, J. / Pawlowska, A. / Falk, P. / Wang, S. / Hitt, D. / Friday, J. / Forman, S. et al. | 2008
- 117
-
Busulfan, Fludarabine and Total Body Irradiation Followed by Allogeneic Peripheral Blood Stem Cell Transplantation is an Effective Treatment for Hematologic Malignancies with Acceptable Toxicity in a Higher-Risk PopulationMeyers, G. / Dunn, A. / Kovacsovics, T. / Fleming, W. / Epner, E. / Hayes-Lattin, B. / Mauro, M. / Deininger, M. / Bubalo, J. / Maziarz, R. et al. | 2008
- 118
-
Efficacy and Toxicity of a Conditioning Regimen with 8-Gy Total Body Irradiation, Fludarabine and Cyclophosphamide for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Hematologic MalignanciesYanagisawa, R. / Nakazawa, Y. / Sakashita, K. / Tanaka, M. / Kamijo, T. / Shiohara, M. / Koike, K. et al. | 2008
- 118
-
Role of Rituximab for Prophylactic or Preemptive Therapy of EBV-DNA-emia and Therapy of EBV-PTLD in HSCT Recipients: a Systematic ReviewStyczynski, J. / Einsele, H. / de la Camara, R. / Engelhard, D. / Reusser, P. / Ward, K. N. / Ljungman, P. et al. | 2008
- 118
-
Recent Trends in Unrelated Donor Stem Cell Transplantation: A Report from the ABMTRRNivison-Smith, I. / Bradstock, K. F. / Dodds, A. J. / Ma, D. D. / Szer, J. et al. | 2008
- 118
-
CD300a and CD300c on Plasmacytoid Dendritic Cells are Down-Regulated by TLR7 and TLR9 Ligand Induced Type I InterferonHart, D. N. / Clark, G. / Ju, X. / Zenke, M. et al. | 2008
- 119
-
The Feasibility of using CCR5D32/D32 Hematopoietic Stem Cell Transplants for Immune Reconstitution in HIV-Infected ChildrenChen, T. K. / Moore, T. B. / Territo, M. / Chow, R. / Tonai, R. / Petz, L. / Rossi, J. / Mitsuyasu, R. / Rosenthal, J. / Forman, S. et al. | 2008
- 119
-
Chronic Graft Versus Host Disease and Pretransplant Disease Status Predict Outcomes in Patients with Hematologic Malignancies Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationShah, M. / Agha, M. / Mapara, M. / Lenhart, K. / Raptis, A. et al. | 2008
- 120
-
Once Daily Busulfan and Fludarabine is well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell TransplantPotter, G. W. / Bachier, C. / Smith, B. / Houghman, M. / LeMaistre, C. F. / Shaughnessy, P. J. et al. | 2008
- 120
-
Safety and Toxicity of Reduced Intensity Allogeneic Transplantation with Fludarabine/Melphalan in Patients with Advanced Haematological Diseases. A Single Centre ExperienceKhoo, L. / Johnston, A. M. / Larsen, S. / Joshua, D. / Gibson, J. et al. | 2008
- 120
-
Second Transplant for Acute Myelogenous Leukemia Relapsing after First TransplantKim, H. J. / Min, W. S. / Eom, K. S. / Cho, B. S. / Lee, S. / Min, C. K. / Cho, S. G. / Kim, D. W. / Lee, J. W. / Kim, C. C. et al. | 2008
- 121
-
Rituximab is Feasible to Administer to Allograft Recipients with Advanced CD20+ Malignancies and does not Affect Timely Hematopoietic EngraftmentKharfan-Dabaja, M. A. / Tate, C. / Perkins, J. / Fernandez, H. F. / Field, T. / Ayala, E. / Perez, L. / Raychaudhuri, J. / Alsina, M. / Ochoa-Bayona, L. et al. | 2008
- 121
-
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia (SAA) using a Non-Myeloablative Conditioning Regimen (NMCR)Rosenthal, J. / Pawlowska, A. / Bolotin, E. / Falk, P. / Oliver, C. / Forman, S. et al. | 2008
- 121
-
Allogeneic Transplantation in Rapid Succession from Two Donors: Immunologic Lesson for Stem Cell EngraftmentZuckerman, T. / Haddad, N. / Katz, T. / Gidoni, O. / Faibish, T. / Rowe, J. M. et al. | 2008
- 122
-
Effect of Smoking on Mobilization of Hematopoietic Stem Cells in Healthy DonorsPanwalkar, A. / Devetten, M. / Loberiza, F. / Moehr, M. / Kessinger, A. et al. | 2008
- 122
-
Alemtuzumab (ALEM) and Continuous-Infusion Pentostatin (PENTO): A Novel Nonmyeloablative (NM) Preparative Regimen for Allogeneic (allo) Hematopoietic Cell Transplantation (HCT)Klinkhammer, T. A. / Carroll, M. P. / Lambert, M. L. / Fung, F. K. / Cantu, E. / Diaz, G. / Trevor, K. / Yeager, A. M. et al. | 2008
- 123
-
Radiation Followed by Mylotarg Plus DLI for Extramedullary Relapse from Acute Myeloid Leukemia Post-allogeneic TransplantSharma, M. / Cumpston, A. / Craig, M. et al. | 2008
- 123
-
Non-Myeloablative Transplantation is a Feasible Option in Patients with Advanced Hematological Malignancies: A Single Center ExperienceGanguly, S. / Vaka, S. / Divine, C. L. / Deauna-Limayo, D. / Bodensteiner, D. C. / Skikne, B. S. et al. | 2008
- 123
-
Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and DiseasesAgura, E. D. / Berryman, R. B. / Fay, J. W. / Pineiro, L. A. / Vance, E. A. / Tadic-Ovcina, M. et al. | 2008
- 123
-
Relative Contribution of CD127 Negative Selection, Rapamycin, and TGF-b to the Generation of Human Regulatory T Cells that Inhibit Alloreactivity via Dendritic Cell ModulationAmarnath, S. / Foley, J. / Mariotti, J. / Costanzo, C. M. / Ryan, K. / Fong, T. / Warner, N. / Fowler, D. H. et al. | 2008
- 124
-
T Cell Receptor Gene Transfer to Virus-Specific T Cells for Cellular Anti-Tumor Immunotherapyvan Loenen, M. M. / Griffioen, M. / van Egmond, H. M. / Hagedoorn, R. S. / Kester, M. / Willemze, R. / Falkenburg, J. H. / Heemskerk, M. H. et al. | 2008
- 124
-
Infliximab Combined with Daclizumab Results in a High Complete Response Rate When used to Treat Acute Steroid Refractory Graft-Versus-Host Disease (SR-GVHD)Srinivasan, R. / Arrington, J. / Karpovich, J. / Donohue, T. / Goodwin, R. / Ramos, C. / Cook, L. / Barrett, J. / Childs, R. et al. | 2008
- 124
-
The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological MalignancyMasmas, T. N. / Johansen, J. V. / Friis-Hansen, L. / Petersen, S. L. / Kornblit, B. / Winther, O. / Nielsen, F. C. / Vindelov, L. L. et al. | 2008
- 125
-
Response to Steroids as Primary Therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem Cell Transplant (HSCT) Recipients: Comparison of Unrelated Donor (URD) Bone Marrow (BM) and Umbilical Cord Blood (UCB)MacMillan, M. L. / Wagner, J. E. / Arora, M. / DeFor, T. E. / Blazar, B. R. / Weisdorf, D. J. et al. | 2008
- 125
-
Allogeneic Antibodies Specifically Target AML Antigen NuSAP1 after Bone Marrow TransplantationWadia, P. P. / Coram, M. / Butte, A. / Miklos, D. B. et al. | 2008
- 126
-
Decreased Risk of Acute GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with the 5,10-Methylenetetrahydrofolate Reductase 677TT GenotypeSugimoto, K. / Murata, M. / Onizuka, M. / Inamoto, Y. / Terakura, S. / Kuwatsuka, Y. / Oba, T. / Miyamura, K. / Kodera, Y. / Naoe, T. et al. | 2008
- 126
-
Off-the-Shelf Tumor Immunotherapy with Genetically Enhanced Allogeneic T-Cell PrecursorsZakrzewski, J. L. / Suh, D. / Markley, J. C. / Smith, O. M. / King, C. / Goldberg, G. / Jenq, R. / Holland, A. M. / Grubin, J. / Cabrera-Perez, J. et al. | 2008
- 126
-
Rapamycin Prevents GVHD in Mouse Model through Novel Mechanism: Increase in Regulatory T cellsPalmer, J. M. / Chen, B. J. / DeOliviera, D. / Le, N. / Chao, N. J. et al. | 2008
- 126
-
Initial Therapy for Acute Graft-Versus-Host Disease with "Low-Dose" Prednisone (1 mg/kg/day) Instead of "Standard-Dose" Prednisone (2 mg/kg/day) does not Compromise Major Outcomes after Allogeneic Hematopoietic Cell TransplantationMielcarek, M. / Storer, B. / Martin, P. J. et al. | 2008
- 127
-
Homeostatic and Inflammatory Processes Contribute to Elevated Plasma Levels of B Cell Activating Factor (BAFF) in Chronic Graft Versus Host Disease (CGVHD)Hakim, F. T. / Rehman, N. / Dickinson, J. / Beal, M. / Baskar, S. / Rader, C. / Cowen, E. / Pavletic, S. / Gress, R. E. et al. | 2008
- 127
-
Human Neutrophil Elastase Stimulating CD4+ and CD8+ T Cells is a Potential Protein Vaccine for Leukemia Patients with Diverse HLA TypesLe, Q. / Melenhorst, J. J. / Hensel, N. / Eniafe, R. / Barrett, A. J. et al. | 2008
- 127
-
Correlation Between FOXP3 Gene Polymorphisms in Donors, and the Severity of Acute Graft-Versus-Host Disease in Patients after Related Allogeneic Stem Cell TransplantationPerfecto-Avalos, Y. / Borbolla Escoboza, J. R. / Villela-Martiez, L. M. / Scott, S. P. / Vela-Ojeda, J. / Gonzalez-Ramella, O. / Baltazar-Arellano, S. / Lopez-Hernandez, M. A. et al. | 2008
- 128
-
Ethylenecarbodiimide (ECDI) Coupled Allogeneic Antigen Presenting Cells Induce Human CD4+ Regulatory T CellsMagg, T. / Yu, X. Z. / Albert, M. H. et al. | 2008
- 128
-
Macrophage Migration Inhibitory Factor as a New Target in Graft-Versus-Host Disease after Allogeneic Stem Cell TransplantationChang, Y. Y. / Miklos, S. / Mueller, G. / Holler, E. / Lindner, P. / Leng, L. / Schubert, T. / Bucala, R. / Hildebrandt, G. C. et al. | 2008
- 128
-
Chronic Graft-Versus-Host Disease (CGVHD) Following Sibling Donor Peripheral Blood Stem Cell Transplant (PBSCT) Versus Bone Marrow Transplant (BMT): Greater Incidence and Longer Duration of Immune-Suppression (DIS) using PBSCArora, M. / Nagaraj, S. / DeFor, T. E. / MacMillan, M. L. / Wagner, J. E. / Burns, L. J. / Weisdorf, D. J. et al. | 2008
- 129
-
Efficient and Selective Prevention of Graft-Versus-Host Disease by Antigen-Specific TGFb-induced Regulatory T cellsYu, X. Z. / Iclozan, C. / Anasetti, C. et al. | 2008
- 129
-
Generation of Treg-like Cells from CD4+CD25- T cells via Epigenetic Modification using a Demethylating Agent DecitabineChoi, J. / Ritchey, J. / DiPersio, J. F. et al. | 2008
- 130
-
GCSF Decreases CD4+CD25+CD127lo Regulatory T Cell Proliferation Index in Stem Cell DonorsKhalili, J. S. / Karandish, S. / Bryan, S. / Molldrem, J. / McMannis, J. / Komanduri, K. V. et al. | 2008
- 130
-
Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)Hamadani, M. / Phillips, G. / Elder, P. / Jansak, B. / Blum, W. / Penza, S. / Lin, T. S. / Farag, S. S. / Devine, S. M. et al. | 2008
- 130
-
Elevated Levels of CD19+ CD21- Transitional B cells in Chronic Graft Versus Host Disease (CGVHD) Associated with Elevated Plasma BAFF Levels and BAFF Receptor ExpressionRehman, N. K. / Dickinson, J. / Baskar, S. / Rader, C. / Pavletic, S. Z. / Gress, R. E. / Hakim, F. T. et al. | 2008
- 131
-
The PTPN22 1858C/T Polymorphism is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative ConditioningKornblit, B. / Masmas, T. / Petersen, S. L. / Madsen, H. O. / Garred, P. / Vindelov, L. et al. | 2008
- 131
-
Graft-Versus-Host Disease: A Minor-Mismatched Mouse Model with Gradual Progression from the Acute into the Chronic PhaseMueller, A. M. / Allen, J. A. / Miklos, D. / Shizuru, J. A. et al. | 2008
- 131
-
Immune Activation with Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Treatment of Relapse after Allogeneic Stem Cell TransplantationBachier, C. R. / Shaughnessy, P. / Smith, B. / Salinas, R. / LeMaistre, C. F. et al. | 2008
- 132
-
The Pharmacodynamic Analysis between Cyclosporine a (CsA) and Cytokine Profiles of CD4+ T Lymphocytes for the Development of Optimized Immunosuppressive Therapy with CsA after Unrelated Cord Blood Transplantation (CBT)Tsukada, N. / Ishige, M. / Konuma, T. / Kato, S. / Kasahara, S. / Tomonari, A. / Ooi, J. / Tojo, A. / Watanabe, N. / Nakauchi, H. et al. | 2008
- 132
-
Where to Biopsy in the Gastrointestinal (GI) Tract to Diagnose Acute Graft Versus Host Disease (AGVHD) in Pediatric Allogeneic Stem Cell Transplant Recipients (alloSCT)Martinez, M. / Billote, G. / Desai, M. / Chu, K. / Remotti, H. / Satwani, P. / Cairo, M. S. / DeFelice, A. et al. | 2008
- 132
-
Incidence and Risk Factors for Chronic Graft-Versus-Host Disease (cGVHD) after Cord Blood Transplantation (CBT)Saliba, R. M. / Couriel, D. / Komanduri, K. / Patah, P. / Westin, J. / Giralt, S. / Cooper, L. / Petropoulos, D. / Worth, L. / Safdar, A. et al. | 2008
- 133
-
The Relationship between Tacrolimus Serum Concentrations and Acute Graft-Versus-Host Disease in Allogeneic Stem Cell RecipientsTrifilio, S. M. / Flickner, S. / Sheldon, S. / Pi, J. / Evens, A. / Frankfurt, O. / Gordon, L. / Singhal, S. / Tallman, M. / Williams, S. et al. | 2008
- 133
-
Early Detection of Severe Acute Graft-Versus-Host Disease using Plasma Markers of T-cell ActivationAugust, K. J. / Chiang, K. Y. / Bostick, R. M. / Waller, E. K. / Langston, A. / Khoury, H. J. / Moore, K. F. / Worthington-White, D. / Rowland, P. / Horan, J. T. et al. | 2008
- 134
-
Different GVHD Clinical Profile among Patients who Received Cord Blood, Compared to those who Received Marrow or Peripheral BloodFunke, V. A. / Nunes, E. C. / Medeiros, L. / Setubal, D. C. / Ruiz, J. / Oliveira, M. M. / Bittencourt, M. A. / Bonfim, C. / Neto, J. Z. / Medeiros, C. R. et al. | 2008
- 134
-
Allospecific Effector Memory T cells have Decreased Ability to Induce Acute GVHDChen, B. J. / Wu, J. / DeOliveira, D. / Chao, N. J. et al. | 2008
- 134
-
Survival after Extracorporeal Photopheresis (ECP) for Treatment of Graft-Versus-Host Disease (GVHD) is Predicted by GVHD Classification as Proposed by National Institute of Health (NIH) Consensus CriteriaJagasia, M. / Stricklin, G. / Logue, M. / Lucid, C. / Fife, H. / Mitchell, J. / Chen, H. / Hunt, C. / Kassim, A. et al. | 2008
- 135
-
Thymoglobulin Binds Natural Killer Cells and Induces Activation and Interferon-g ProductionDardari, R. / Dalle, J. H. / Menezes, J. / Cordeiro, P. / Champagne, M. / Duval, M. et al. | 2008
- 135
-
Reduced Relapse Related Death (RRD) in Alternative Donor Transplants with EBV/CMV ReactivationBacigalupo, A. / Tedone, E. / Soracco, M. / Frassoni, F. / Van Lint, M. T. et al. | 2008
- 135
-
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Adults| 2008
- 135
-
Extracorporeal Photochemotherapy (ECP) for Steroid-Refractory Graft-Versus-Host Disease (GVHD) in Low-Weight Pediatric Patients. Changes in L-selectin Expression by T Lymphocytes and Clinical OutcomeGonzalez-Vicent, M. / Ramirez, M. / Perez, A. / Sevilla, J. / Diaz, M. A. et al. | 2008
- 136
-
Co-transplantation of Human Tregs and CD34+ Cells: A Preclinical StudyMahmud, D. / Chunduri, S. / Mahmud, N. / Van den Dries, L. / Maciejewski, J. / Rondelli, D. et al. | 2008
- 136
-
Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed against Mismatched HLA Class IAmir, A. / Hagedoorn, R. S. / Marijt, E. A. / Willemze, R. / Falkenburg, J. H. / Heemskerk, M. H. et al. | 2008
- 136
-
What is the Role for Regulatory T-cells after Nonmyeloablative Conditioning?Humblet-Baron, S. / Castermans, E. / Vanbellighen, J. F. / Hannon, M. / Jacobs, N. / Beguin, Y. / Baron, F. et al. | 2008
- 137
-
PUVA Therapy for Acute Graft-Versus-Host Disease (GVHD) of the SkinFurlong, T. / Appelbaum, F. R. / Carpenter, P. A. / Deeg, J. / Doney, K. / Flowers, M. E. / Kiem, H. P. / Martin, P. J. / Mielcarek, M. / Nash, R. A. et al. | 2008
- 137
-
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myelogenous Leukemia in Adults: An Evidence-Based ReviewOliansky, D. M. / Appelbaum, F. / Cassileth, P. A. / Keating, A. / Kerr, J. / Nieto, Y. / Stewart, S. / Stone, R. M. / Tallman, M. S. / McCarthy, P. L. et al. | 2008
- 137
-
The Analysis of Chronic GVHD after Cord Blood Transplantation in Comparison with Bone Marrow TransplantationSeo, S. / Uchida, N. / Yamamoto, H. / Takagi, S. / Tsuji, M. / Kato, D. / Matsuno, N. / Masuoka, K. / Wake, A. / Taniguchi, S. et al. | 2008
- 137
-
Persistent Recipient Antigen-Presenting Cells in Human Hematopoietic Stem Cell Transplantation: Identification of a Dermal Subset that Outlives Epidermal Langerhans CellsHaniffa, M. / Ginhoux, F. / Abel, M. / Bullock, S. / Alshemali, S. / Merad, M. / Collin, M. P. et al. | 2008
- 138
-
Low Dose Anti-Thymocyte Globulin for Graft-Versus-Host Disease Prophylaxis of Mismatched Unrelated Peripheral Blood Stem Cell Transplantation in Adult Patients with Acute Myelogenous LeukemiaKim, H. J. / Min, W. S. / Eom, K. S. / Cho, B. S. / Min, C. K. / Lee, S. / Cho, S. G. / Lee, J. W. / Kim, C. C. et al. | 2008
- 138
-
Intra-arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD)Shapira, M. Y. / Bloom, A. I. / Or, R. / Resnick, I. B. / Aker, M. / Bitan, M. / Slavin, S. / Verstandig, A. et al. | 2008
- 138
-
Tacrolimus, Sirolimus and Antithymocyte Globulin (rATG) for Graft Versus Host Disease Prophylaxis for Unrelated Donor Hematopoietic Cell TransplantationAljitawi, O. S. / Nakamura, R. / Palmer, J. / Senitzer, D. / Pullarkat, V. / Briggs, A. / Cai, J. L. / Rosenthal, J. / Schriber, J. / Snyder, D. et al. | 2008
- 139
-
b2 Intergrins Separates Graft-versus-host Disease and Graft-versus-leukemia EffectYu, X. Z. / Liang, Y. / Liu, C. / Djeu, J. Y. / Zhong, B. / Peters, T. / Scharffetter-Kochanek, K. / Anasetti, C. et al. | 2008
- 139
-
Elucidating the Role of the Fas-Fasl Pathway during Cutaneous GVHD Across Minor Histocompatibility Antigens in vitroArditti, F. D. / Friedman, T. / Korngold, R. et al. | 2008
- 139
-
Alefacept Treatment for Chronic Extensive Graft Versus Host DiseaseShapira, M. Y. / Resnick, I. B. / Bitan, M. / Tsirigotis, P. / Aker, M. / Gesundeheidt, B. / Slavin, S. / Or, R. et al. | 2008
- 139
-
Sildenafil (Revatio) Therapy in Chronic Graft Versus Host Disease (cGVHD): Improvement in Pulmonary cGVHD SymptomsBauer, S. S. / Dao, C. / Cashen, A. / Vij, R. / Stockerl-Goldstein, K. / Uy, G. L. / Westervelt, P. / DiPersio, J. F. / Abboud, C. N. et al. | 2008
- 140
-
Monocyte Blood Count and Acute GVHD: Flow Cytometry Analysis Recommended in Prospective StudiesChunduri, S. / Arpinati, M. / Singh, V. / Shuaipaj, T. / Mehta, J. / Rondelli, D. et al. | 2008
- 140
-
Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Graft-versus-host Disease (GVHD) Prophylaxis after Hematopoietic Cell Transplantation from Unrelated DonorsFurlong, T. / Kiem, H. P. / Appelbaum, F. R. / Carpenter, P. A. / Deeg, J. / Doney, K. / Flowers, M. E. / Mielcarek, M. / Nash, R. A. / Storb, R. et al. | 2008
- 140
-
Daclizumab and Infliximab for Treatment of Steroid Resistant Acute Graft Versus Host Disease (aGVHD) in PediatricsSnyder, R. L. / Daum, C. / Klinger, E. / Neudorf, S. / Simpson, L. et al. | 2008
- 141
-
Eosinophilic Pulmonary Syndrome as a Manifestation of Pulmonary Graft-versus-host-disease Following Hematopoietic Stem Cell Transplantation in Three PatientsAkhtari, M. / Lanston, A. / Waller, E. / Gal, A. et al. | 2008
- 141
-
Effect of Acute and Chronic GVHD on Overall Survival in 122 Unrelated Transplants for Malignant Diseases Performed Over Ten Years in a Single Center in BrazilFunke, V. A. / Nunes, E. C. / Medeiros, L. / Setubal, D. C. / Ruiz, J. / Oliveira, M. M. / Bittencourt, M. A. / Bonfim, C. / Neto, J. Z. / Medeiros, C. R. et al. | 2008
- 141
-
Primary Treatment and Prognosis of Acute Graft-versus-host Disease (GVHD): A Single-center Analysis of 458 PatientsFukuda, T. / Yokoyama, H. / Takahashi, T. / Iisaka, Y. / Ohara-Waki, F. / Kim, S. W. / Mori, S. I. / Tanosaki, R. / Tobinai, K. / Takaue, Y. et al. | 2008
- 142
-
Delayed Recovery of Myeloid (mDC) and Plasmacytoid (pDC) Dendritic Cells at 3 Months after Allogeneic HSC Transplantation Correlates with an Increased Transplant-related and Overall Mortality Independently of GVHDArpinati, M. / Chirumbolo, G. / Nicolini, B. / De Vivo, A. / Bonifazi, F. / Giannini, M. B. / Giovannini, M. / Bandini, G. / Martelli, V. / Stanzani, M. et al. | 2008
- 142
-
Cyclosporine a (CSA) Significantly Reduces the Cytotoxic Effects of in vitro Expanded NK Cells: Implications for Adoptive NK Cell Therapy in the Setting of Allogeneic Hematopoietic Stem Cell (HCT) TransplantationYokoyama, H. / Berg, M. / Lundqvist, A. / McCoy, J. P. / Srivastava, S. / Smith, A. / Childs, R. et al. | 2008
- 142
-
Rituximab Infusion after Allogeneic HCT Prevents Donor B Cell Reconstitution and Alloimmunity One Year Post TransplantSahaf, B. / Chen, G. / Boiko, J. / Heydari, K. / Arai, S. / Miklos, D. et al. | 2008
- 143
-
Presence of Activating KIR Genotypes Influences Cytomegalovirus (CMV) Reactivation as Detected by Q-PCR in HCT RecipientsSun, J. / Gallez-Hawkins, G. M. / Thao, L. / Li, X. / Franck, A. E. / Dagis, A. / Senitzer, D. / Forman, S. J. / Zaia, J. A. et al. | 2008
- 143
-
Impact of Donor T Cells on B Cell Development after Hematopoietic Cell Transplantation: Lessons from B Cell Deficient MiceMueller, A. M. / Allen, J. A. / Miklos, D. / Tung, J. W. / Shizuru, J. A. et al. | 2008
- 143
-
Vaccination with Carnarypox pp65 CMV Vaccine Induces Reliable CD4+ and CD8+ T Cell Responses only in Individuals Who Lack Baseline Responses. Implications for Donor Vaccination to Boost CMV Immunity in Stem Cell Transplant RecipientsShenoy, A. / Solomon, S. / Pichon, S. / Cadoz, M. / Barrett, A. J. et al. | 2008
- 144
-
Minimal Residual Disease and Chimerism in CML Patients Receiving Allogeneic Transplants after Myeloablative or Reduced ConditioningUzunel, M. / Mattsson, J. / Hauzenberger, D. / Ringden, O. et al. | 2008
- 144
-
Transcriptional Analysis of CD4+ T Cells from Tolerant Patients and Normal Controls. Gene Expression in Patients Differs from Normal ControlsTabellini, L. / Haeusermann, P. / Bumgarner, T. E. / Flowers, M. E. / Grogan, B. M. / Martin, P. J. / Hansen, J. A. et al. | 2008
- 144
-
B Lymphocyte Reconstitution Following Allogeneic Stem Cell Transplantation for Haematological Disorders: Correlation with Pre- and Post-Transplant FactorsRichardson, D. S. / Hodges, E. / Mani, A. / Hurlock, C. / Newman, J. / McKeag, N. / Hill, K. / Orchard, K. H. et al. | 2008
- 145
-
Melan-A Specific Umbilical Cord Blood (UCB) T Cells Show Evidence of Cytolytic Function and Persistence in the UCB Pediatric Transplant RecipientMerindol, N. K. / Caty, M. / Gimmig, S. / Duval, M. / Champagne, M. / Soudeyns, H. et al. | 2008
- 145
-
Examining Human TCR CDR3 Diversity during LymphopeniaMemon, S. A. / Gress, R. E. / Hakim, F. T. et al. | 2008
- 145
-
Resident Human Myeloid Dendritic Cell Activation and Local Allogeneic T Cell Responses in the Bone Marrow of Humanized NOD/SCID MiceHart, D. N. / Vuckovic, S. / Alison, R. M. / Kato, M. / Khalil, D. / Fadilah, S. A. / Rodwell, R. et al. | 2008
- 146
-
Fate of the CD4+FoxP3+ Subset within the Total CD4+ T Cell Population Following BMTZilberberg, J. / Friedman, T. M. / Korngold, R. et al. | 2008
- 146
-
Reconstitution of TCR Repertoire Diversity via Homeostatic Proliferation after Bone Marrow TransplantationZilberberg, J. / Friedman, T. M. / Korngold, R. et al. | 2008
- 146
-
PD-1 Expression is Linked to CMV Disease and Prolonged CMV Infection after HCTGallez-Hawkins, G. M. / Thao, L. / Palmer, J. / Li, X. / Franck, A. E. / Lacey, S. F. / Diamond, D. J. / Forman, S. J. / Zaia, J. A. et al. | 2008
- 146
-
Day 15 Dendritic Cell Recovery Predicts Overall Survival after Autologous Stem Cell Transplantation in non-Hodgkins lymphomaSiddiqui, M. A. / Markovic, S. N. / Nevala, W. K. / Morice, W. / Inwards, D. J. / Ansell, S. M. / Micallef, I. N. / Johnston, P. B. / Porrata, L. et al. | 2008
- 147
-
Perception of Knowledge of the Stem Cell Transplant (SCT) Process and Evaluation of SCT Team Member Functions by Caregiver(s): A Comparison between Childhood Malignant and Non-Malignant Disorder Transplant FamiliesChadakhtzian, A. L. / Heidotten, A. / Yocco, M. / Barnes, Y. J. / Shenoy, S. et al. | 2008
- 147
-
Plasmatic TNF-a, IL-2, IFN-g and IL-10 are important Cytokines to Control CML after Allogeneic Stem Cell TransplantAnjos, A. R. / Silva, L. / Kaneno, R. / Calvi, S. / Oliveira, J. S. et al. | 2008
- 147
-
Effect of IL-7 on Human NK CellsMichaud, A. / Dardari, R. / Charrier, E. / Cordero, P. / Duval, M. et al. | 2008
- 147
-
Mad about Steroids: Nursing Management of the SCT Patient with Steroid-induced PsychosisSwitzer, M. A. et al. | 2008
- 148
-
Pre-stem Cell Transplant Education Effect on Patient Anxiety LevelsScherer, T. M. et al. | 2008
- 148
-
Total Glucose Control (TGC): A Glucose Control Project for Staff NursesLatchford, T. M. / Knoepfel, R. et al. | 2008
- 148
-
Whose Who? a Brown Bag Lunch Program for the Stanford Blood and Marrow Transplant Inpatient StaffLatchford, T. M. et al. | 2008
- 148
-
Rituximab Monitoring in Hematopoietic Stem Cell Transplant: How much is Necessary?Blackburn, R. K. / Wood, G. / Mick, J. M. / Munsell, M. S. / Neumann, J. / Johnston, P. et al. | 2008
- 149
-
Caring for the Morbidly Obese Hematopoietic Stem Cell Transplant Patient: Nursing Interventions and ImplicationsBlue, K. / Neumann, J. / Giralt, S. / Switzer, M. et al. | 2008
- 149
-
70% Ethanol Locks in the Role of Preventing/Treating Catheter Related BacteraemiaSanders, J. M. et al. | 2008
- 149
-
Prophylactic and Treatment Regimens for MucositisBlackstock, J. L. / Frey, M. A. et al. | 2008
- 149
-
Multidiscliplinary Intervention of Admission PlanningLarson, S. M. et al. | 2008
- 150
-
Making Heart Success: Educating Nurses about a Heart Failure ProgramKnape, C. / Martin, A. / Colleen, L. / Ramos, J. / Schuling, E. / Granada, M. et al. | 2008
- 150
-
A Retrospective Analysis Comparing the Direct Costs Associated with the use of G-CSF Alone and G-CSF and Chemotherapy in Stem Cell MobilizationWasko, M. / Johnson, M. / Sirilla, J. et al. | 2008
- 150
-
Characteristics of HSCT and Oncology Patient Fallers and their Falls in an Ambulatory Cancer CenterWickline, M. M. et al. | 2008
- 150
-
An Educated Patient is a Safe PatientBreen, A. W. et al. | 2008
- 151
-
Pediatric Pheresis Leg Splint Immobilization to Increase Efficiency Of Stem Cell Collection and Control Femoral Pheresis Catheter MalfunctionsYocco, M. / Healy, D. / Barnes, Y. / Chadakhtzian, A. / Heidotten, A. / Shenoy, S. / Hayashi, R. et al. | 2008
- 151
-
Efficacy of Mouth Rinses during Cytarabine Infusion in Preventing Oral Mucositis in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Conditioned by High-dose Cytarabine and Total Body IrrradiationHasegawa, K. / Okabe, A. / Kawada, Y. / Tsujimura, N. / Yashima, T. / Kobayashi, N. / Kondo, S. / Mori, T. / Okamoto, S. et al. | 2008
- 151
-
Lower Leg Muscle Strength and Fatigue in Patients Receiving Hematopoietic Cell Transplantation up to two Months after Hospital DischargeTonosaki, A. et al. | 2008
- 151
-
Implementation of a Developmental form to Improve Communication and Foster Clinical Development for the Blood and Marrow Transplant Nurse after the Orientation Period EndsEllison, L. M. et al. | 2008
- 152
-
Supporting the Scleroderma Patient through a Complex Total Body Irradiation Preparative Regimen with Autolgous Stem Cell Support: A Multidisciplinary ApproachRussell, D. / Lassiter, M. / Loftis, J. et al. | 2008
- 152
-
Methodological Considerations in Physical and Psychosocial Intervention Studies in Patients Undergoing Hematopoietic Stem Cell Transplantation (SCT)Laursen, H. B. / Jarden, M. / Adamsen, L. et al. | 2008
- 152
-
Infusion Confusion: How to Teach the Art of HPC InfusionKramer, C. P. / Fouts, T. V. / Rogers, K. / Naert, S. / Nista, E. / Garner, K. et al. | 2008
- 153
-
Obtaining Financial Coverage for Stem Cell Transplantation: Utilizing Creative StrategiesCruz, E. D. / Hinson, P. / Shaw, S. / Adkison, R. / Lewis, M. et al. | 2008
- 153
-
A Synergistic Dialogue: Clinical Nurses and Academic Researchers in PartnershipBarnes, Y. J. / Hendricks-Ferguson, V. L. / Oakley, B. / Roll, L. / Stegenga, K. / Haase, J. E. et al. | 2008
- 154
-
Clinically Relevant Surface Bacteria in an Outpatient Oncology FacilityWilson, D. E. / Romero, K. / Little, K. / Webb, S. C. et al. | 2008
- 154
-
From the Ground up: Building a Patient and Family Support Program for the University of North Carolina Hospitals Bone Marrow and Stem Cell Transplant ProgramTalbert, G. / Covington, D. / Hinshaw, B. / ODell, P. / Sharf, S. / Kivette, K. et al. | 2008
- 154
-
Using Peer Presentations to Meet the Education Needs of Blood & Marrow Transplant Nurses: Increasing Knowledge and Promoting RetentionSullivan, L. M. et al. | 2008
- 155
-
Stem Cell Transplantation Patient Family Caregivers: A Program Focused on "Caring for the Caregiver"Adornetto-Garcia, D. L. / Williams, L. A. / Jackson, A. / Norman, L. / Lederleitner, C. / Mir, M. et al. | 2008
- 155
-
Successful Integration of Complementary Therapies in a Combined Adult and Pediatric Bone Marrow Transplant UnitMueller, K. / Farmer, A. / Talbert, G. / Shea, T. et al. | 2008
- 155
-
Preventing Falls for Hematopoietic Stem Cell PatientsWood, J. M. / Schuldt, T. L. / Eilers, J. et al. | 2008
- 155
-
Nursing Care of the Bone Marrow Transplant Patient in Septic Shock with Acute Respiratory Distress SyndromeMulholland, K. et al. | 2008
- 156
-
Pass it onHarris, L. N. / Guess, C. W. / Frey, M. A. / Kurtzberg, J. et al. | 2008
- 156
-
Effects of Guided Imagery on Hematopoietic Stem Cell Transplantation PatientsKim, H. S. et al. | 2008
- 156
-
Becoming a Primary Site for the Radiation Injury Treatment Network (RITN): Are you Prepared?Laub, L. M. et al. | 2008
- 157
-
A Retrospective Analysis Comparing Infection Rates during Mobilization of Stem Cells Prior to Autologous TransplantJohnson, M. / Sirilla, J. / Wasko, M. et al. | 2008
- 157
-
Discharge Education Class: Helping to Ease the Burden of BMT CaregiversRimkus, C. F. / Duisen, E. / Gallagher, D. / Austin, P. et al. | 2008
- 157
-
A Specialty Clinic for Pediatric Hematopoietic Stem Cell Transplant Patients with Chronic Graft-versus-host DiseaseMaterazzo, M. / Lehmann, L. / Duncan, C. et al. | 2008
- 157
-
Development of an Outpatient Fall Prevention Program in an Ambulatory Cancer CenterWickline, M. M. et al. | 2008
- 158
-
Nurse Practitioner Leadership Development - a Model Designed to Develop Leadership Skills and Enhance the Efficacy of the Nurse Practitioner Role at a University Affiliated Medical Center Bone Marrow Transplant DepartmentRomvari, E. / Bauer, S. / Bryant, G. / Comer, H. / Ruettgers, E. et al. | 2008
- 158
-
Innovative Sharing of the BMT Message and the Collateral BenefitsThirlwell, S. / Siderakis, C. / Brand, L. K. / Daily, K. / Dame, B. / Davis, A. / Elstner, C. / Hillgruber, R. / LaFave, D. / McKeen-Yearsley, A. et al. | 2008
- 158
-
Psychosocial Adjustment and Quality of Life in Couples Prior to Hematopoietic Cell TransplantationTierney, D. K. et al. | 2008
- 159
-
The Case Study Approach: Bridging Gaps in Nursing EducationGuess, C. / Stanton, T. / Frey, M. A. et al. | 2008
- 159
-
"What am i Getting into?": Developing a GVHD Class for Pretransplant PatientsQuinn, J. et al. | 2008
- 159
-
Developing a Comprehensive BMT Specific ICU Training Program for Competent BMT NursesRimkus, C. F. et al. | 2008
- 160
-
Denials and Appeals Processing made Major Impact in Patient Accessing Stem Cell TransplantationHontiveros, R. L. / Champlin, R. E. et al. | 2008
- 160
-
Implementing a Process to Update Referring Physicians Regarding Unrelated Donor Search ActivityWehde, M. A. et al. | 2008
- 160
-
Plasma B-type Natriuretic Peptide: Its Role in Pediatric Hematopoietic Stem Cell Transplantation and Implications for NursesBertin, H. D. / Koontz, S. E. / Petropoulos, D. / Worth, L. L. / Lee, D. A. / Cooper, L. J. et al. | 2008
- 161
-
Double Cord Blood Transplants in Pediatric Patients: Implications for Nurses - what is all the Hype about?Carstens, K. A. / Ortiz, J. M. / Koontz, S. E. / Worth, L. L. / Petropoulos, D. / Lee, D. A. / de Lima, M. J. / Shpall, E. / Cooper, L. J. et al. | 2008
- 161
-
Nursing Guidelines for the Management of Stem Cell Transplant Patients with Thrombotic Thrombocytopenic PurpuraBabino, E. M. / Estrella, J. M. et al. | 2008
- 161
-
Zap that Energy Back: Engaging the Stem Cell Transplant Patient in Tertiary ActivitiesEstrella, J. M. / Granada, M. L. et al. | 2008
- 161
-
A Practical Tool for Newly Specializing NursesHogan, M. B. et al. | 2008
- 162
-
Mapping Graft Versus Host Disease after Allogeneic Stem Cell Transplant-a Prospective Approach to Recognize and Capture Signs and Symptoms of Graft Versus Host Disease (GVHD) and Evaluate Treatment EffectivenessRomvari, E. / Ruettgers, E. et al. | 2008
- 162
-
The ABCS of Blood and Marrow Transplantation: A Training Program for Pediatric Oncology NursesProkopiou, C. / De La Cruz, D. et al. | 2008
- 162
-
Breaking the Silence: Uncovering Sexuality in Stem Cell TransplantationGranada, M. A. / Estrella, J. M. et al. | 2008
- 163
-
Domains of Decision making in Quaternary HSCT ResearchShannon-Dorcy, K. K. / Drevdahl, D. J. et al. | 2008
- 163
-
Standardizing Central Venous Line Care in Inpatient Pediatric Hematopoietic Stem Cell Transplant Recipients: Does it Make a Difference in Reducing Catheter Related Blood Stream Infection Rates?Barrell, C. / Covington, L. / Kaplan, M. / Baldinger, L. / Martone, D. / Vitale, K. / Schwartz, S. / Cairo, M. S. / Saiman, L. / Monica, B. et al. | 2008
- 163
-
Exercise in Patients Receiving Intensive Cancer Therapy: Results from a Feasibility StudyHacker, E. D. / Larson, J. L. / Peace, D. et al. | 2008
- 164
-
Priority Concerns of Patients Receiving Autologous or Allogeneic Stem Cell Transplants at the Seattle Cancer Care AllianceKlein, C. / Berry, D. L. / Fann, J. / Halpenny, B. / Lober, W. / Wolpin, S. / Bush, N. et al. | 2008
- 164
-
Appropriate ICU Utilization for BMT PatientsJenkins, T. L. et al. | 2008
- 164
-
Defining the Symptom Burden of Chronic Graft Versus Host DiseaseWilliams, L. A. / Couriel, D. R. / Neumann, J. L. / Whisenant, M. S. / Galbizo, E. O. / Cleeland, C. S. et al. | 2008
- 165
-
High Rate of Revaccination in Allogeneic and Early Autologous Stem Cell Transplantation - Results of a Single Center Compliance Tracking SurveyWest, K. / Brown, K. / Paplham, P. / Privitere, L. / Syta, M. / Battiwalla, M. / Smiley, S. / McCarthy, P. L. et al. | 2008
- 165
-
Methotrexate and Piperacillin/Tazobactam Versus Methotrexate and Ceftazidime: A Look at Time to Engraftment and Side Effect Profile Differences in Hematopoietic Stem Cell Transplant PatientsHoffmann, P. D. / Haight, A. E. et al. | 2008
- 165
-
Clonazepam Plus Levetiracetam (CL) for the Prevention of Busulfan-Induced Seizures: A Single Center ExperienceBubalo, J. S. / Kovascovics, T. J. / Meyers, G. / Mauro, M. / Epner, E. / Hayes-Lattin, B. / Deininger, M. / Curtin, P. T. / Leis, J. F. / Maziarz, R. T. et al. | 2008
- 166
-
Pre-transplant Busulfan Test Dose is a Reliable Alternative to First Busulfan IV Dose for Pharmacokinetics Studies in Allogeneic Hematopoietic Stem Cell TransplantationBeri, R. / Chunduri, S. / Mactal-Haaf, C. / Sweiss, K. / Dobogai, L. / Hurter, B. / Shord, S. / Peace, D. / Rondelli, D. et al. | 2008
- 166
-
An Aprepitant Containing Regimen Controls the Delayed Nausea and Vomiting Associated with High-dose Melphalan Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple MyelomaBechtel, T. P. / Crawford, B. S. / Gordon, S. M. / Penza, S. / Hofmeister, C. / Benson, D. / Devine, S. et al. | 2008
- 166
-
Successful Technological Implementation at an Inner City Medical CenterRobinson, N. / Dumercy, D. / Simon, N. / Willumsen, S. / Roberts, S. / Barredo, J. / Kleiner, G. et al. | 2008
- 166
-
Rabbit ATG (thymoglobulin r) Pharmacokinetics in Pediatric Patients Receiving a Matched Unrelated Donor Bone Marrow TransplantationCall, S. K. / Kasow, K. / Barfield, R. / Leung, W. / Madden, R. / Horwitz, E. / Woodard, P. / Yusuf, U. / Panetta, J. C. / Baker, S. et al. | 2008
- 167
-
Evaluation of 2 IV Busulfan Pediatric Dosing GuidelinesDupuis, L. L. / Schechter, T. / Ansari, M. / Gassas, A. / Theoret, Y. / Champagne, M. A. / Doyle, J. et al. | 2008
- 167
-
Why are some Stem Cell Transplant Candidates (SCT) not Finally Transplanted? the Experience of a SCT Team using an Electronic Tool to Manage the Transplant ScheduleBalsalobre, P. / Buno, I. / Gayoso, J. / Serrano, D. / Munoz, C. / Gomez-Pineda, A. / Diez-Martin, J. L. et al. | 2008
- 169
-
ASBMT 2008 Author Index| 2008
- 181
-
Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myelogenous Leukemia Patients Older Than 40 YearsHuisman, C. / Meijer, E. / Petersen, E. J. / Lokhorst, H. M. / Verdonck, L. F. et al. | 2008
- 187
-
HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTRSchlenk, R. F. / Pasquini, M. C. / Perez, W. S. / Zhang, M. J. / Krauter, J. / Antin, J. H. / Bashey, A. / Bolwell, B. J. / Buchner, T. / Cahn, J. Y. et al. | 2008
- 197
-
Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose RegimensSaito, A. M. / Cutler, C. / Zahrieh, D. / Soiffer, R. J. / Ho, V. T. / Alyea, E. P. / Koreth, J. / Antin, J. H. / Lee, S. J. et al. | 2008
- 208
-
Elevated Numbers of Immature/Transitional CD21- B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host DiseaseGreinix, H. T. / Pohlreich, D. / Kouba, M. / Kormoczi, U. / Lohmann, I. / Feldmann, K. / Zielinski, C. / Pickl, W. F. et al. | 2008
- 220
-
High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant RegimenGeddes, M. / Kangarloo, S. B. / Naveed, F. / Quinlan, D. / Chaudhry, M. A. / Stewart, D. / Savoie, M. L. / Bahlis, N. J. / Brown, C. / Storek, J. et al. | 2008
- 229
-
Cardiac Chamber Hypertrophy following Hematopoietic Stem Cell Transplantation for Primary ImmunodeficiencyBulley, S. R. / Benson, L. / Grunebaum, E. / Roifman, C. M. et al. | 2008
- 236
-
Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative ConditioningHari, P. / Carreras, J. / Zhang, M. J. / Gale, R. P. / Bolwell, B. J. / Bredeson, C. N. / Burns, L. J. / Cairo, M. S. / Freytes, C. O. / Goldstein, S. C. et al. | 2008
- 246
-
Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative DisordersLaport, G. G. / Sandmaier, B. M. / Storer, B. E. / Scott, B. L. / Stuart, M. J. / Lange, T. / Maris, M. B. / Agura, E. D. / Chauncey, T. R. / Wong, R. M. et al. | 2008
- 256
-
Sirolimus Associated Pneumonitis after Nonmyeloablative Peripheral Blood Stem Cell Transplant for Sickle Cell DiseaseHsieh, M. M. / Link, M. B. / Tisdale, J. F. et al. | 2008
- A7
-
Table of Contents| 2008
-
Officers and Directors of ASBMT| 2008
-
Masthead| 2008
-
Editorial Board| 2008